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ABSTRACT
Background While there is a long history of measuring death and 
disability from injuries, modern research methods must account for 
the wide spectrum of disability that can occur in an injury, and must 
provide estimates with sufficient demographic, geographical and 
temporal detail to be useful for policy makers. The Global Burden of 
Disease (GBD) 2017 study used methods to provide highly detailed 
estimates of global injury burden that meet these criteria.
Methods In this study, we report and discuss the methods used in 
GBD 2017 for injury morbidity and mortality burden estimation. In 
summary, these methods included estimating cause- specific mortality 
for every cause of injury, and then estimating incidence for every cause 
of injury. Non- fatal disability for each cause is then calculated based 
on the probabilities of suffering from different types of bodily injury 
experienced.
Results GBD 2017 produced morbidity and mortality estimates for 
38 causes of injury. Estimates were produced in terms of incidence, 
prevalence, years lived with disability, cause- specific mortality, years 
of life lost and disability- adjusted life- years for a 28- year period for 22 
age groups, 195 countries and both sexes.
Conclusions GBD 2017 demonstrated a complex and sophisticated 
series of analytical steps using the largest known database of morbidity 
and mortality data on injuries. GBD 2017 results should be used to 
help inform injury prevention policy making and resource allocation. We 
also identify important avenues for improving injury burden estimation 
in the future.
INTRODUCTION
The Global Burden of Disease (GBD) study is a comprehen-
sive assessment of population health loss. GBD has expanded 
in scope since its original release in 1994 (GBD 1990) and was 
most recently updated in autumn 2018 (GBD 2017).1–7 Each 
update of the study has provided updated results through the 
most recent year of data availability as well as increasingly 
refined detail in terms of locations, age groups and causes. In 
addition, GBD incorporates new data as well as updated methods 
for each annual release that represent the expanding complexity 
of the study. Cumulatively, the increasing volume of data and 
increasingly sophisticated estimation methods have necessitated 
near- continual refinements in terms of data processing, statis-
tical modelling, computational storage and processing as well as 
global collaboration with the over 4000 GBD collaborators in 
over 140 countries and territories.
Historically, injuries have formed one of the three broad cause 
groups in the GBD cause hierarchy alongside the other two main 
groups of health loss (communicable, maternal, neonatal and 
nutritional diseases; non- communicable diseases). Not surpris-
ingly, there is considerable variation in how morbidity and 
mortality are estimated across different causes in the GBD hier-
archy and study design. The methods for estimating morbidity 
and mortality from injuries have evolved over time through the 
most recent release of GBD 2017. Historically, there have been 
certain challenges in injuries burden estimation, some of which 
have been addressed and updated over time, and some of which 
remain as methodological challenges to address as population 
health measurement develops more sophisticated modelling 
strategies. For example, methodological challenges that have 
been identified over the past three decades in population health 
research have included obtaining data in data- sparse, burden- 
heavy areas of the world, developing adjustments for ill- defined 
causes of death, separately estimating cause of injury from the 
bodily harm that results from an injury event and adjusting for 
known biases in data, such as underestimation in sexual violence 
data.3 8 9 Cumulatively, the global injuries research community 
has developed a wide array of methodological innovations and 
advancements to overcome many of these challenges, although 
undoubtedly the science will continue to advance as higher- 
quality datasets become available, as modelling methods improve 
and as computational processing power becomes more accessible 
to population health research groups around the world.
Many studies have been published based on different releases 
of the GBD study, ranging from studies on intentional injuries in 
the eastern Mediterranean to detailed assessments of traumatic 
brain injury and spinal cord injury disability rates on a global 
scale.10 11 While this array of published GBD injury studies 
demonstrates a broad spectrum of expert knowledge on specific 
injuries or specific geographies or both, it is also critical to recog-
nise that population health is a rapidly evolving, collaborative 
science that has benefited from near- continual improvements 
even through the current updates being implemented for GBD 
2019. As a result, it should benefit the scientific enterprise to 
focus on publishing the most updated results with perspective on 
global, demographic and temporal patterns, and on sharing iter-
ative updates on the current state of the science of GBD injuries 
burden estimation. The goal of this study is to comprehensively 
review and report methods used for GBD 2017 and associated 
publications that have gone through extensive collaborator- 
review and peer- review processes.
METHODS
GBD 2017 study
GBD is predicated on the principle that every case of death and 
disability in the population should be systematically identified 
and accounted for in the formulation of global disease and injury 
burden. On the side of mortality, every death that occurs in the 
population should have one underlying cause of death which 
can be assigned to a cause in a mutually exclusive, collectively 
exhaustive hierarchy of diseases and injuries that can cause 
death. These data can be used in a method described below to 
calculate cause- specific mortality rates and years of life lost. For 
morbidity, every non- fatal case of disease or injury should have 
an amount of disability assigned for some period of time. These 
data can be used in a process described below to estimate the 
incidence, prevalence and years lived with disability. Summing 
morbidity and mortality from some cause form the burden from 
that cause, expressed as disability- adjusted life- years (DALY). For 
causes with known risk factors, some portion of this burden may 
be explained by exposure to that risk factor. Across causes within 
some population, it is also a principle of GBD that the sum of 
all cause- specific deaths should equal all- cause mortality in the 
population, and that rates of incidence, prevalence, remission 
and cause- specific mortality can be reconciled with one another 
such that all death and disability in a population is internally 
consistent across causes and geographies. As examples, the sum 
of different types of road injury cases must sum up to overall 
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Table 1 Global Burden of Disease cause- of- injury hierarchy
Transport injuries
Unintentional 
injuries
Self- harm and 
interpersonal 
violence
Forces of nature, 
conflict and terrorism 
and executions and 
police conflict
Road injuries Falls Self- harm Exposure to forces of 
nature
Pedestrian road 
injuries
Drowning Self- harm by firearm Conflict and terrorism
Cyclist road injuries Fire, heat and hot 
substances
Self- harm by other 
specified means
Executions and police 
conflict
Motorcyclist road 
injuries
Poisonings Interpersonal violence
Motor vehicle road 
injuries
Poisoning by carbon 
monoxide
Assault by firearm
Other road injuries Poisoning by other 
means
Assault by sharp object
Other transport 
injuries
Exposure to 
mechanical forces
Assault by other means
Unintentional firearm 
injuries
Unintentional 
suffocation
Other exposure to 
mechanical forces
Adverse effects of 
medical treatment
Animal contact
Venomous animal 
contact
Non- venomous 
animal contact
Foreign body
Pulmonary aspiration 
and foreign body in 
airway
Foreign body in eyes
Foreign body in other 
body part
Environmental heat 
and cold exposure
Other unintentional 
injuries
road injuries, and the sum of deaths from different injuries 
in a given country must sum up to the estimate of all- injury 
deaths. The principle of internal consistency extends to popu-
lations used in GBD, where every birth, death and net migra-
tion must be accounted for in the population estimates which 
form the denominators of GBD results. While there is immense 
complexity in the process summarised above, it is important to 
begin with these core principles which govern the computation 
processes at the heart of GBD burden estimation. A summarised 
overview of key GBD 2017 methods is also provided in online 
supplementary appendix 1.
GBD study design and hierarchies
GBD study design, including cause- specific methods, is described 
in a high level of detail in associated publications.2–7 In addi-
tion to the injury- focused methods described in this paper, it is 
important to define hierarchies used in the GBD study design. 
In particular, GBD 2017 was built around a location hierarchy 
where different subnational locations (eg, US states, India states, 
China provinces) which form a composite of a national location 
(eg, the USA, India, China). National locations are aggregated 
to form GBD regions, which are then aggregated to form GBD 
super regions. These designations affect the modelling structure 
and utilisation of location random effects, processes which are 
described in more detail later. The country- level and regional- 
level GBD location hierarchy used in GBD 2017 is provided in 
online supplementary appendix table 1. In addition to locations, 
GBD processes are conducted to produce estimates for every 
one of 22 age groups, male and female sex and across 28 years 
from 1990 to 2017 (inclusive). Age- standardised, all- age and 
combined sex results are also computed for each GBD result. 
Exceptions exist to the rules above, for example, self- harm is not 
permitted to occur in the 0–6 days (early neonatal) age group 
in the GBD age hierarchy. There are no sex restrictions placed 
on any GBD injury causes, although these restrictions exist for 
other GBD causes, such as cancers like prostate, cervical and 
uterine being related to one sex.
GBD injury classification
In the GBD cause hierarchy, injuries are part of the first level of 
the GBD cause hierarchy, which consists of three broad groups: 
communicable, maternal, neonatal and nutritional diseases; 
non- communicable diseases and injuries. Additional levels of the 
GBD cause hierarchy provide additional detail. The hierarchy 
of injuries in GBD is provided in table 1. The organisation of 
the hierarchy has implications both in terms of how results are 
produced and in terms of analytical and processing steps which 
are discussed in more detail below. Case definitions including 
International Classification of Diseases (ICD) codes used to 
identify injury deaths and cases are provided in table 2.
GBD separates the concept of cause of injury from nature of 
injury. Cause of injury (eg, road injuries, falls, drowning) have 
historically been used for assigning cause of death as opposed to 
the ‘nature’ of injury, which more directly specifies the pathology 
that resulted in death. For example, an individual who falls, 
fractures his or her hip, undergoes surgery and then develops 
hospital- acquired pneumonia and dies while hospitalised would 
still have a fall as the underlying cause of death, regardless of 
whether sepsis or some other disease process leads to death 
more proximally in the chain of events. In this individual, the 
‘nature’ of injury would have been specified as a hip fracture, 
since it is the bodily injury that would dictate the disability this 
person experiences. Since it is evident that a hip fracture is more 
disabling than a mild skin abrasion, it is important for measuring 
non- fatal burden to consider both the cause and the nature in 
the formulation of complete injury burden. A full list of nature 
of injury is provided in table 3.
Cause-specific mortality and years of life lost
As described above, cause- specific mortality is measured for every 
cause of injury in the GBD cause hierarchy with the exception of 
foreign body in the ear and sexual violence, which undergo only 
non- fatal burden estimation (described in more detail below). 
GBD adheres to five general principles for measuring cause- 
specific mortality, which are described in more detail elsewhere 
but are summarised as follows.12 First, GBD 2017 identifies all 
available data. For injuries, this includes vital registration (VR), 
vital registration samples, verbal autopsy (VA), police records 
and mortuary/hospital data. VR is the preferred data source but 
is not available in every location in the GBD location hierarchy. 
Prior VA research has demonstrated that VA is more accurate 
for certain injury causes than it is for certain diseases.13 Police 
data undergo additional validity checks to ensure that systematic 
under- reporting does not occur in comparison to VR data, which 
is described in more detail in a related publication.6 The second 
general principle relevant to injury mortality estimation is maxi-
mising comparability and quality of the dataset. For the purposes 
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Table 2 Case definitions for cause of injury in GBD 2017
Child causes ICD codes Case definition (fatal) Case definition (non- fatal)
Self- harm ICD9: E950- E959
ICD10: X60- X64.9, X66- X84.9, Y87.0
Deliberate bodily damage inflicted on oneself resulting in 
death
Deliberate bodily damage inflicted on oneself with or without 
intent to kill oneself.
Self- harm by firearm ICD9: E955- E955.9
ICD10: X72- X74.9
Deliberate bodily damage inflicted by firearm on oneself 
resulting in death
Deliberate bodily damage inflicted on oneself by firearm with or 
without intent to kill oneself.
Self- harm by other specified means ICD9: E950- E954, E956- E958.0, E958.2- E959
ICD10: X60- X64.9, X66- X67.9, X69- X71.9, X75-
X75.9, X77- X84.9, Y87.0
Deliberate bodily damage inflicted on oneself resulting in 
death by means of:*
 ► Self- poisoning
 ► Medication overdose
 ► Transport incident
 ► Falling from height
 ► Hanging/strangulation
*(not exhaustive)
Deliberate bodily damage inflicted on oneself with or without 
intent to kill oneself by means of:*
 ► Self- poisoning
 ► Medication overdose
 ► Transport incident
 ► Falling from height
 ► Hanging/strangulation
*(not exhaustive)
Poisoning ICD9: E850.3- E858.99, E862- E869.99, E929.2
ICD10: J70.5, X40- X44.9, X47- X49.9, Y10- Y14.9, 
Y16- Y19.9
Death resulting from accidental exposure to a non- infectious 
substance which contacts the body or enters into the body 
via inhalation, ingestion, injection or absorption and causes 
deranged physiological function of body and/or cellular 
injury/death.
Unintentional exposure to a non- infectious substance which 
contacts the body or enters into the body via inhalation, 
ingestion, injection or absorption and causes deranged 
physiological function of body and/or cellular injury/death.
Poisoning by carbon monoxide (CO) ICD9: E862- E862.99, E868- E869.99
ICD10: J70.5, X47- X47.9
Death from exposure to carbon monoxide (CO) as identified 
based on carboxyhemoglobin levels (specified based on 
smoking status and age) or proximity to a confirmed CO 
poisoning case. 
 
Non- fatal exposure to CO as identified based on 
carboxyhemoglobin levels (specified based on smoking status 
and age) or proximity to a confirmed CO poisoning case.
 
Poisoning by other means ICD9: E850.3- E858.99, E866- E866.99
ICD10: X40- X44.9, X49- X49.9, Y10- Y14.9, 
Y16- Y19.9
Death resulting from accidental exposure to a non- infectious 
substance (other than CO) which contacts the body or 
enters into the body via inhalation, ingestion, injection or 
absorption and causes deranged physiological function of 
body and/or cellular injury/death.
Accidental exposure to a non- infectious substance (other 
than CO) which contacts the body or enters into the body 
via inhalation, ingestion, injection or absorption and causes 
deranged physiological function of body and/or cellular injury/
death.
Animal contact ICD9: E905- E906.99
ICD10: W52.0- W62.9, W64- W64.9, X20- X29.9
Death resulting from unintentionally being attacked, struck, 
impaled, bitten, stung, crushed, exposed to or stepped on by 
a non- human animal.
Bodily damage resulting from unintentionally being attacked, 
butted, impaled, bitten, stung, crushed, exposed to or stepped 
on by a non- human animal.
Venomous animal contact ICD9: E905- E905.99
ICD10: W52.3, X20- X29.9
Death resulting from unintentionally being bitten by, stung 
by, or exposed to a non- human venomous animal.
Bodily damage resulting from unintentionally being bitten by, 
stung by or exposed to a non- human venomous or poisonous 
animal.
Non- venomous animal contact ICD9: E905- E906.99
ICD10: W52.0- W62.9, W64- W64.9, X20- X29.9
Death resulting from unintentionally being attacked, struck, 
impaled, crushed, exposed to or stepped on by a non- human 
animal.
Bodily damage resulting from unintentionally being attacked, 
struck, impaled, crushed, exposed to or stepped on by a non- 
human animal.
Falls ICD9: E880- E886.99, E888- E888.9, E929.3
ICD10: W00- W19.9
A sudden movement downwards due to slipping, tripping or 
other accidental movement which results in a person coming 
to rest inadvertently on the ground, floor or other lower 
level, resulting in death.
A sudden movement downward due to slipping, tripping or 
other accidental movement which results in a person coming 
to rest inadvertently on the ground, floor or other lower level, 
resulting in tissue damage.
Drowning ICD10: W65- W70.9, W73- W74.9
ICD9: E910- E910.99
Death that occurs as a result of immersion in water or 
another fluid.
Non- fatal immersion or submersion in water or another fluid, 
regardless of whether tissue damage has occurred. The subject 
can be resuscitated and has not suffered brain death.
Fire, heat, and hot substances ICD9: E890- E899.09, E924- E924.99, E929.4
ICD10: X00- X06.9, X08- X19.9
Death due to unintentional exposure to substances of high 
temperature sufficient to cause tissue damage on exposure, 
including bodily contact with hot liquid, solid or gas such as 
cooking stoves, smoke, steam, drinks, machinery, appliances, 
tools, radiators and objects radiating heat energy.
Unintentional exposure to substances of high temperature 
sufficient to cause tissue damage on exposure, including bodily 
contact with hot liquid, solid or gas such as cooking stoves, 
smoke, steam, drinks, machinery, appliances, tools, radiators and 
objects radiating heat energy.
Road injuries ICD9: E800.3, E801.3, E802.3, E803.3, E804.3,
E805.3, E806.3, E807.3, E810.0- E810.6,
E811.0- E811.7, E812.0- E812.7, E813.0-
E813.7, E814.0- E814.7, E815.0- E815.7,
E816.0- E816.7, E817.0- E817.7, E818.0-
E818.7, E819.0- E819.7, E820.0- E820.6,
E821.0- E821.6, E822.0- E822.7, E823.0-
E823.7, E824.0- E824.7, E825.0- E825.7,
E826.0- E826.1, E826.3- E826.4, E827.0,
E827.3- E827.4, E828.0, E828.4, E829.0-
E829.4
ICD10: V01- V04.99, V06- V80.929, V82- V82.9,
V87.2- V87.3
Interaction with an automobile, motorcycle, pedal cycle or 
other vehicles resulting in death.
Interaction with an automobile, motorcycle, pedal cycle or other 
vehicles resulting in bodily damage.
Pedestrian road injuries ICD9: E811.7, E812.7, E813.7, E814.7, E815.7,
E816.7, E817.7, E818.7, E819.7, E822.7,
E823.7, E824.7, E825.7, E826.0, E827.0,
E828.0, E829.0
ICD10: V01- V04.99, V06- V09.9
Interaction, as a pedestrian on the road, with an automobile, 
motorcycle, pedal cycle or other vehicles resulting in death.
Interaction, as a pedestrian on the road, with an automobile, 
motorcycle, pedal cycle or other vehicles resulting in bodily 
damage.
Cyclist road injuries ICD9: E800.3, E801.3, E802.3, E803.3, E804.3,
E805.3, E806.3, E807.3, E810.6, E811.6,
E812.6, E813.6, E814.6, E815.6, E816.6,
E817.6, E818.6, E819.6, E820.6, E821.6,
E822.6, E823.6, E824.6, E825.6, E826.1
ICD10: V10- V19.9
Accident, as a cyclist or passenger on a pedal cycle, resulting 
in death.
Accident, as a cyclist or passenger on a pedal cycle, resulting in 
bodily damage.
Motorcyclist road injuries ICD9: E810.2- E810.3, E811.2- E811.3, E812.2-
E812.3, E813.2- E813.3, E814.2- E814.3,
E815.2- E815.3, E816.2- E816.3, E817.2-
E817.3, E818.2- E818.3, E819.2- E819.3,
E820.2- E820.3, E821.2- E821.3, E822.2-
E822.3, E823.2- E823.3, E824.2- E824.3,
E825.2- E825.3
ICD10: V20- V29.9
Accident, as a rider on a motorcycle, resulting in death. Accident, as a rider on a motorcycle, resulting in bodily damage.
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Child causes ICD codes Case definition (fatal) Case definition (non- fatal)
Motor vehicle road injuries ICD9: E810.0- E810.1, E811.0- E811.1, E812.0-
E812.1, E813.0- E813.1, E814.0- E814.1,
E815.0- E815.1, E816.0- E816.1, E817.0-
E817.1, E818.0- E818.1, E819.0- E819.1,
E820.0- E820.1, E821.0- E821.1, E822.0-
E822.1, E823.0- E823.1, E824.0- E824.1,
E825.0- E825.1
ICD10: V30- V79.9, V87.2- V87.3
Accident, as a driver or passenger in a motor vehicle, 
resulting in death.
Accident, as a driver or passenger in a motor vehicle, resulting 
in bodily damage.
Other road injuries ICD9: E810.4- E810.5, E811.4- E811.5, E812.4-
E812.5, E813.4- E813.5, E814.4- E814.5,
E815.4- E815.5, E816.4- E816.5, E817.4-
E817.5, E818.4- E818.5, E819.4- E819.5,
E820.4- E820.5, E821.4- E821.5, E822.4-
E822.5, E823.4- E823.5, E824.4- E824.5,
E825.4- E825.5, E826.3- E826.4, E827.3-
E827.4, E828.4, E829.4
ICD10: V80- V80.929, V82- V82.9
Death resulting from being a driver or passenger of a 
vehicle not including automobiles, motorcycles, bicycles (ie, 
streetcar).
Bodily damage resulting from being a driver or passenger of 
a vehicle not including automobiles, motorcycles, bicycles (ie, 
streetcar).
Other transport injuries ICD9: E800- E800.2, E801- E801.2, E802- E802.2,
E803- E803.2, E804- E804.2, E805- E805.2,
E806- E806.2, E807- E807.2, E810.7,
E820.7, E821.7, E826.2, E827.2, E828.2,
E830- E838.9, E840- E849.9, E929.1
ICD10: V00- V00.898, V05- V05.99, V81- V81.9,
V83- V86.99, V88.2- V88.3, V90- V98.8
Interaction with a means of transport other than automobile, 
motorcycle, pedal cycle or other road vehicles resulting in 
death.
Interaction with a means of transport other than automobile, 
motorcycle, pedal cycle or other road vehicles resulting in bodily 
damage.
Interpersonal violence ICD9: E960- E969
ICD10: X85- Y08.9, Y87.1- Y87.2
Death from intentional use of physical force or power, 
threatened or actual, from another person or group not 
including military or police forces.
Sustaining bodily harm in terms of tissue damage from 
intentional use of physical force or power, threatened or actual, 
from another person or group not including military or police 
forces.
Physical violence by firearm ICD9: E965- E965.4
ICD10: X93- X95.9
Death from intentional use of physical force or power by 
a firearm from another person or group or community not 
including military or police forces.
Sustaining bodily harm in terms of tissue damage from 
intentional use of physical force or power by a firearm from 
another person or group not including military or police forces.
Physical violence by sharp object ICD9: E966
ICD10: X99- X99.9
Death from intentional use of physical force or power by a 
sharp object from another person or group or community not 
including military or police forces.
Sustaining bodily harm in terms of tissue damage from 
intentional use of physical force or power by a sharp object from 
another person or group not including military or police forces.
Sexual violence ICD9: E960- E960.1
ICD10: Y05- Y05.9
NA Experiencing at least one event of sexual violence in the last 
year, where sexual violence is defined as any sexual assault, 
including both penetrative sexual violence (rape) and non- 
penetrative sexual violence (other forms of unwanted sexual 
touching).
Physical violence by other means ICD9: E961- E964, E965.5- E965.9, E967- E969
ICD10: X85- X92.9, X96- X98.9, Y00- Y04.9, Y06-
Y08.9, Y87.1- Y87.2
Death from intentional use of physical force or power by 
an object other than a firearm or sharp object from another 
person or group or community not including military or 
police forces.
Sustaining bodily harm in terms of tissue damage from 
intentional use of physical force or power by an object other 
than a firearm or sharp object from another person or group not 
including military or police forces.
Conflict and terrorism ICD9: E979- E979.9, E990- E999.1
ICD10: U00- U03, Y36- Y38.9, Y89.1
Death resulting from the instrumental use of violence by 
people who identify themselves as members of a group—
whether this group is transitory or has a more permanent 
identity—against another group or set of individuals, in 
order to achieve political, economic or social objectives.
Bodily harm resulting from the instrumental use of violence 
by people who identify themselves as members of a group—
whether this group is transitory or has a more permanent 
identity—against another group or set of individuals, in order to 
achieve political, economic or social objectives.
Executions and police conflict ICD9: E970- E978
ICD10: Y35- Y35.93, Y89.0
State- sanctioned executions or police- related altercations 
leading to death.
State- sanctioned executions or police- related altercations 
leading to bodily damage.
Exposure to forces of nature ICD9: E907- E909.9
ICD10: X33- X38.9
Death resulting from an unforeseen and often sudden 
natural event such as a hurricane, earthquake, tsunami or 
tornado.
Bodily damage resulting from an unforeseen and often sudden 
natural event such as a hurricane, earthquake, tsunami or 
tornado.
Exposure to mechanical forces ICD9: E913- E913.19, E916- E922.99, E928.1-
E928.7
ICD10: W20- W38.9, W40- W43.9, W45.0- W45.2,
W46- W46.2, W49- W52, W75- W76.9
Unintentional death resulting from contact with or threat of 
an (in)animate object, human or plant.
Unintentional bodily damage resulting from contact with or 
threat of an (in)animate object, human or plant.
Unintentional firearm injuries ICD9: E922- E922.99, E928.7
ICD10: W32- W34.9
Unintentional death resulting from contact with a firearm. Unintentional bodily damage resulting from contact with a 
firearm.
Other exposure to mechanical forces ICD9: E916- E921.99, E928.1- E928.6
ICD10: W20- W31.9, W35- W38.9, W40- W43.9,
W45.0- W45.2, W46- W46.2, W49- W52
Unintentional death resulting from contact with or threat 
of an (in)animate object (not including a firearm), human 
or plant.
Unintentional bodily damage resulting from contact with or 
threat of an (in)animate object (not including a firearm), human 
or plant.
Pulmonary aspiration and foreign body 
in airway
ICD9: 770.1–770.18, E911- E912.09, E913.8-
E913.99
ICD10: W78- W80.9, W83- W84.9
Unintentional death from inhaling, swallowing or aspirating 
extraneous materials or substance that enters the airway 
or lungs.
Unintentional bodily damage from inhaling, swallowing or 
aspirating extraneous materials or substance that enters the 
airway or lungs.
Foreign body in eyes ICD9: 360.5–360.69, 374.86, 376.6, E914-
E914 09
ICD10: H02.81- H02.819, H44.6- H44.799
NA Unintentional damage from extraneous materials or substance 
in the orbital structure or eye.
Foreign body in other body part ICD9: 709.4, E915- E915.09
ICD10: M60.2- M60.28, W44- W45, W45.3- W45.9
Unintentional death from an extraneous material or 
substance being within the body, not including the airway, 
lungs or eyes.
Unintentional bodily damage from an extraneous material or 
substance being within the body, not including the airway, 
lungs or eyes.
Injuries definition: damage, defined by cellular death, tissue disruption, loss of homeostasis, pain limiting activities of daily living or short- term psychological harm (for cases of sexual violence), inflicted on the body as the direct or indirect result of 
a physical force, immersion or exposure, which may include interpersonal or self- inflicted forces.
GBD, Global Burden of Disease; ICD, International Classification of Diseases.
Table 2 Continued
of injury mortality estimation, this process is largely focused 
on (1) ensuring appropriate accounting for different ICD code 
versions used for cause of death data classification over time, (2) 
redistribution of ill- defined causes of death (described in more 
detail elsewhere) and (3) processing VA studies into usable data 
that map to the GBD cause hierarchy.8 9 12 The third general prin-
ciple for injury cause of death models in GBD 2017 is to develop 
a diverse set of plausible models. This process is conducted via 
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Table 3 GBD nature of injury
Nature of injury
Amputation of lower limbs, bilateral Fracture of sternum and/or fracture of one or more ribs Crush injury
Amputation of upper limbs, bilateral Fracture of vertebral column Nerve injury
Amputation of fingers (excluding thumb) Fracture of femur, other than femoral neck Injury to eyes
Amputation of lower limb, unilateral Minor TBI Poisoning requiring urgent care
Amputation of upper limb, unilateral Moderate/severe TBI Severe chest injury
Amputation of thumb Spinal cord lesion at neck level Internal haemorrhage in abdomen and pelvis
Amputation of toe/toes Spinal cord lesion below neck level Effect of different environmental factors
Lower airway burns Muscle and tendon injuries, including sprains and strains 
lesser dislocations
Complications following therapeutic procedures
Burns, <20% total burned surface area without lower airway burns Foreign body in ear Multiple fractures, dislocations, crashes, wounds, 
pains and strains
Burns, ≥20% total burned surface area or ≥10% burned surface area if head/neck 
or hands/wrist involved without lower airway burns
Open wound(s)
Fracture of clavicle, scapula or humerus Contusion in any part of the body
Fracture of face bones Superficial injury of any part of the body
Fracture of foot bones except ankle Dislocation of hip
Fracture of hand (wrist and other distal part of hand) Dislocation of knee
Fracture of hip Dislocation of shoulder
Fracture of patella, tibia or fibula or ankle Foreign body in respiratory system
Fracture of pelvis Foreign body in GI and urogenital system
Fracture of radius and/or ulna Drowning and non- fatal submersion
Fracture of skull Asphyxiation
GBD, Global Burden of Disease; GI, gastrointestinal; TBI, traumatic brain injury.
the Cause of Death Ensemble model (CODEm) framework, 
which is the standard, peer- reviewed cause of death estimation 
process used extensively in the GBD study. CODEm generates 
a large set of possible models based on covariates suggested by 
the modeller based on expert input and literature review (eg, 
alcohol for road injuries) and then runs every plausible model, 
which can range into the thousands per cause. These models can 
be conducted in both rate space and cause fraction space and use 
an assortment of combinations among the user- selected covari-
ates (table 4). Fourth, the predictive validity of each one of these 
submodels is tested using test- train holdouts, whereby a specific 
model is trained on a portion of data and tested on a separate 
portion to determine out- of- sample predictive validity. Once the 
submodels are conducted and predictive validity is measured, 
then an ensemble model is developed out of the submodels. The 
submodels and the ensemble model are then subject to the fifth 
principle, which is to choose the best- performing models based 
on out- of- sample predictive validity. The chosen models may be 
a single cause model or an ensemble of models. Beyond these 
processes, which have become automated with expert review in 
the GBD processing architecture, there is also considerable time 
required by the analysts, modellers, collaborators and principal 
investigators who are involved in the GBD study. Such processes 
also come under expert scrutiny via the GBD Scientific Council 
and the peer- review process in the annual GBD capstone 
publications.2–7
Once submodels and ensemble models have been conducted 
for each cause in the GBD cause hierarchy, a process to correct 
for cause of death rates to ensure internal consistency is 
conducted. Specifically, each subcause within some overall cause 
is rescaled such that, for example, every subtype of road inju-
ries sums to road injuries deaths overall, and then road injuries 
and other transport injuries sum to equal the overall transport 
injuries cause. As this cascades to the overall cause hierarchy 
and the overall all- cause mortality rates, cause- specific mortality 
across all causes ultimately equals the overall mortality in the 
population. An example of an injuries cause of death model with 
vital registration data (Colombia, females) is shown in figure 1. 
A similar model with relatively less data is shown in figure 2 
(Honduras, females). While data are absent in more recent years 
in Honduras, the model is still able to follow temporal trends, age 
patterns and broader geographical patterns by harnessing signals 
from covariate- based fixed effects (eg, alcohol consumption per 
capita) and location- based random effects (eg, the regional trends 
in Central Latin America and patterns in neighbouring coun-
tries). All cause of death models from GBD 2017 are publicly 
available for review (https:// vizhub. healthdata. org/ cod/). Cause- 
specific deaths are converted to cause- specific mortality rates 
(CSMRs) using GBD populations. Once CSMRs are established, 
years of life lost (YLLs) are computed as the product of CSMRs 
and residual life expectancy at the age of death. The residual life 
expectancy is based on the lowest observed mortality rate for 
each age across all populations over 5 million. For example, if 
a death from road injuries occurs at age 25 and the residual life 
expectancy is 60 years, then there are 60 YLLs attributed to that 
death. If the death had occurred at age 50 with a residual life 
expectancy of 38 years, then 38 YLLs would be attributed. Life 
tables used for GBD 2017 are provided in related publications. 7
Injury incidence, prevalence and years lived with disability
After cause- specific models for each cause of injury in the GBD 
cause hierarchy are conducted, the non- fatal estimation process 
is conducted. An overview of this process is depicted in figure 3. 
In the first stage, we estimate the incidence of injuries warranting 
medical care using DisMod- MR 2.1 (abbreviated DisMod). 
DisMod is a meta- regression tool for epidemiological estimation 
that uses a compartmental model structure whereby a healthy 
population may become diseased or injured, at which point the 
individual either remains a prevalent case, goes into remission or 
dies. DisMod essentially fits differential equations to reconcile 
the transitions between these different compartments, so that 
the final posterior estimate for each epidemiological param-
eter can be explained in the context of the other parameters. 
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Table 4 Covariates used in GBD cause of death models
Cause Global or data- rich model Sex Number of 
covariates used
Covariates used
Transport injuries Global/Data rich Male 10 Alcohol (litres per capita), Education (years per capita), Lag distributed income per capita (I$), Population 
Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), Rainfall 
Quintile 5 (proportion), Vehicles–two+four wheels (per capita), Vehicles–two wheels fraction (proportion), 
Sociodemographic Index, Healthcare Access and Quality Index
Transport injuries Global/Data rich Female 10 Alcohol (litres per capita), Education (years per capita), Lag distributed income per capita (I$), Population 
Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), Rainfall 
Quintile 5 (proportion), Vehicles–two+four wheels (per capita), Vehicles–two wheels fraction (proportion), 
Sociodemographic Index, Healthcare Access and Quality Index
Road injuries Global/Data rich Male 13 Alcohol (liters per capita), Education (years per capita), Lag distributed income per capita (I$), Population 15 to 
30 (proportion), Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, 
proportion), Vehicles–two+four wheels (per capita), Vehicles–two wheels (per capita), Vehicles - 4 wheels (per 
capita), Vehicles–two wheels fraction (proportion), Log- transformed summary exposure value (SEV) scalar: Road 
Inj, Sociodemographic Index, Healthcare Access and Quality Index
Road injuries Global/Data rich Female 13 Alcohol (liters per capita), Education (years per capita), Lag distributed income per capita (I$), Population 15 to 
30 (proportion), Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, 
proportion), Vehicles–two+four wheels (per capita), Vehicles–two wheels (per capita), Vehicles - 4 wheels (per 
capita), Vehicles–two wheels fraction (proportion), Log- transformed SEV scalar: Road Inj, Sociodemographic 
Index, Healthcare access and quality index
Pedestrian road 
injuries
Global/Data rich Male 11 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–two+four wheels 
(per capita), Vehicles–two wheels fraction (proportion), Log- transformed SEV scalar: Pedest, Sociodemographic 
Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Pedestrian road 
injuries
Global/Data rich Female 11 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–two+four wheels 
(per capita), Vehicles–two wheels fraction (proportion), Log- transformed SEV scalar: Pedest, Sociodemographic 
Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Cyclist road injuries Global/Data rich Male 10 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Vehicles–two+four wheels (per capita), Vehicles - two 
wheels fraction (proportion), Log- transformed SEV scalar: Cyclist, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Cyclist road injuries Global/Data rich Female 10 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Vehicles - two+four wheels (per capita), Vehicles–two 
wheels fraction (proportion), Log- transformed SEV scalar: Cyclist, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Motorcyclist road 
injuries
Global/Data rich Male 10 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–two wheels (per 
capita), Log- transformed SEV scalar: Mot Cyc, Sociodemographic Index, Healthcare Access and Quality Index, Lag 
distributed income per capita (I$)
Motorcyclist road 
injuries
Global/Data rich Female 10 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–two wheels (per 
capita), Log- transformed SEV scalar: Mot Cyc, Sociodemographic Index, Healthcare Access and Quality Index, Lag 
distributed income per capita (I$)
Motor vehicle road 
injuries
Global/Data rich Male 10 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–four wheels (per 
capita), Log- transformed SEV scalar: Mot Veh, Sociodemographic Index, Healthcare Access and Quality Index, Lag 
distributed income per capita (I$)
Motor vehicle road 
injuries
Global/Data rich Female 10 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–four wheels (per 
capita), Log- transformed SEV scalar: Mot Veh, Sociodemographic Index, Healthcare Access and Quality Index, Lag 
distributed income per capita (I$)
Other road injuries Global/Data rich Male 8 Alcohol (liters per capita), Rainfall Quintile 5 (proportion), Vehicles–two+four wheels (per capita), Vehicles–two 
wheels fraction (proportion), Log- transformed SEV scalar: Oth Road, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Other road injuries Global/Data rich Female 8 Alcohol (liters per capita), Rainfall Quintile 5 (proportion), Vehicles–two+four wheels (per capita), Vehicles–two 
wheels fraction (proportion), Log- transformed SEV scalar: Oth Road, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Other transport 
injuries
Global/Data rich Male 11 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–two+four wheels 
(per capita), Vehicles–two wheels fraction (proportion), Log- transformed SEV scalar: Oth Trans, Sociodemographic 
Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Other transport 
injuries
Global/Data rich Female 11 Alcohol (liters per capita), Education (years per capita), Population Density (300–500 ppl/sqkm, proportion), 
Population Density (500–1000 ppl/sqkm, proportion), Rainfall Quintile 5 (proportion), Vehicles–two+four wheels 
(per capita), Vehicles–two wheels fraction (proportion), Log- transformed SEV scalar: Oth Trans, Sociodemographic 
Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Falls Global/Data rich Male 7 Alcohol (liters per capita), Elevation Over 1500 m (proportion), Log- transformed SEV scalar: Falls, 
Sociodemographic Index, milk adjusted(g), Healthcare Access and Quality Index, Lag distributed income per 
capita (I$)
Falls Global/Data rich Female 7 Alcohol (liters per capita), Elevation Over 1500 m (proportion), Log- transformed SEV scalar: Falls, 
Sociodemographic Index, milk adjusted(g), Healthcare Access and Quality Index, Lag distributed income per 
capita (I$)
Drowning Global/Data rich Male 10 Alcohol (liters per capita), Coastal Population within 10 km (proportion), Education (years per capita), Landlocked 
Nation (binary), Elevation Under 100 m (proportion), Rainfall Quintile 1 (proportion), Rainfall Quintile 5 
(proportion), Log- transformed SEV scalar: Drown, Sociodemographic Index, Lag distributed income per capita (I$)
Drowning Global/Data rich Female 10 Alcohol (liters per capita), Coastal Population within 10 km (proportion), Education (years per capita), Landlocked 
Nation (binary), Elevation Under 100 m (proportion), Rainfall Quintile 1 (proportion), Rainfall Quintile 5 
(proportion), Log- transformed SEV scalar: Drown, Sociodemographic Index, Lag distributed income per capita (I$)
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Fire, heat and hot 
substances
Global/Data rich Male 9 Alcohol (liters per capita), Tobacco (cigarettes per capita), Education (years per capita), Indoor Air Pollution 
(All Cooking Fuels), Population Density (over 1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Fire, 
Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Fire, heat and hot 
substances
Global/Data rich Female 9 Alcohol (liters per capita), Tobacco (cigarettes per capita), Education (years per capita), Indoor Air Pollution 
(All Cooking Fuels), Population Density (over 1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Fire, 
Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Poisonings Global/Data rich Male 8 Education (years per capita), Opium Cultivation (binary), Population Density (over 1000 ppl/sqkm, proportion), 
Population Density (under 150 ppl/sqkm, proportion), Log- transformed SEV scalar: Poison, Sociodemographic 
Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Poisonings Global/Data rich Female 8 Education (years per capita), Opium Cultivation (binary), Population Density (over 1000 ppl/sqkm, proportion), 
Population Density (under 150 ppl/sqkm, proportion), Log- transformed SEV scalar: Poison, Sociodemographic 
Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Poisoning by carbon 
monoxide
Global/Data rich Male 4 Education (years per capita), Lag distributed income per capita (I$), Sociodemographic Index, Healthcare Access 
and Quality Index
Poisoning by carbon 
monoxide
Global/Data rich Female 4 Education (years per capita), Lag distributed income per capita (I$), Sociodemographic Index, Healthcare access 
and quality index
Poisoning by other 
means
Global/Data rich Male 4 Education (years per capita), Lag distributed income per capita (I$), Sociodemographic Index, Healthcare access 
and quality index
Poisoning by other 
means
Global/Data rich Female 4 Education (years per capita), Lag distributed income per capita (I$), Sociodemographic Index, Healthcare access 
and quality index
Exposure to 
mechanical forces
Global/Data rich Male 7 Alcohol (liters per capita), Education (years per capita), Population Density (over 1000 ppl/sqkm, proportion), 
Population Density (under 150 ppl/sqkm, proportion), Sociodemographic Index, Healthcare access and quality 
index, Lag distributed income per capita (I$)
Exposure to 
mechanical forces
Global/Data rich Female 7 Alcohol (liters per capita), Education (years per capita), Population Density (over 1000 ppl/sqkm, proportion), 
Population Density (under 150 ppl/sqkm, proportion), Sociodemographic Index, Healthcare access and quality 
index, Lag distributed income per capita (I$)
Unintentional firearm 
injuries
Global/Data rich Male 9 Alcohol (liters per capita), Education (years per capita), Health System Access (unitless), Population Density (over 
1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Log- transformed SEV scalar: 
Mech Gun, Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Unintentional firearm 
injuries
Global/Data rich Female 9 Alcohol (liters per capita), Education (years per capita), Health System Access (unitless), Population Density (over 
1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Log- transformed SEV scalar: 
Mech Gun, Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Other exposure to 
mechanical forces
Global/Data rich Male 9 Alcohol (liters per capita), Education (years per capita), Health System Access (unitless), Population Density (over 
1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Log- transformed SEV scalar: 
Oth Mech, Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Other exposure to 
mechanical forces
Global/Data rich Female 9 Alcohol (liters per capita), Education (years per capita), Health System Access (unitless), Population Density (over 
1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Log- transformed SEV scalar: 
Oth Mech, Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Adverse effects of 
medical treatment
Global/Data rich Male 3 Lag distributed income per capita (I$), Sociodemographic Index, Healthcare Access and Quality Index
Adverse effects of 
medical treatment
Global/Data rich Female 3 Lag distributed income per capita (I$), Sociodemographic Index, Healthcare Access and Quality Index
Animal contact Global/Data rich Male 11 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population 15 to 
30 (proportion), Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, 
proportion), Elevation Under 100 m (proportion), Log- transformed SEV scalar: Animal, Sociodemographic Index, 
Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Animal contact Global/Data rich Female 11 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population 15 to 
30 (proportion), Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, 
proportion), Elevation Under 100 m (proportion), Log- transformed SEV scalar: Animal, Sociodemographic Index, 
Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Venomous animal 
contact
Global/Data rich Male 10 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 m 
(proportion), Log- transformed SEV scalar: Venom, Sociodemographic Index, Healthcare Access and Quality Index, 
Lag distributed income per capita (I$)
Venomous animal 
contact
Global/Data rich Female 10 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 m 
(proportion), Log- transformed SEV scalar: Venom, Sociodemographic Index, Healthcare Access and Quality Index, 
Lag distributed income per capita (I$)
Non- venomous animal 
contact
Global Male 6 Alcohol (liters per capita), Education (years per capita), Lag distributed income per capita (I$), Log- transformed 
SEV scalar: Non Ven, Sociodemographic Index, Healthcare Access and Quality Index
Non- venomous animal 
contact
Data rich Male 10 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 
m (proportion), Log- transformed SEV scalar: Non Ven, Sociodemographic Index, Healthcare Access and Quality 
Index, Lag distributed income per capita (I$)
Non- venomous animal 
contact
Global/Data rich Female 10 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 
m (proportion), Log- transformed SEV scalar: Non Ven, Sociodemographic Index, Healthcare Access and Quality 
Index, Lag distributed income per capita (I$)
Foreign body Global Male 10 Education (years per capita), Indoor Air Pollution (All Cooking Fuels), Population Density (over 1000 ppl/sqkm, 
proportion), Population Over 65 (proportion), Sociodemographic Index, Healthcare Access and Quality Index, Lag 
distributed income per capita (I$)
Foreign body Global Female 10 Education (years per capita), Indoor Air Pollution (All Cooking Fuels), Population Density (over 1000 ppl/sqkm, 
proportion), Population Over 65 (proportion), Sociodemographic Index, Healthcare Access and Quality Index, Lag 
distributed income per capita (I$)
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Pulmonary aspiration 
and foreign body in 
airway
Global/Data rich Male 6 Alcohol (liters per capita), Lag distributed income per capita (I$), Mean BMI, Log- transformed SEV scalar: F Body 
Aspn, Sociodemographic Index, Access and Quality Index
Pulmonary aspiration 
and foreign body in 
airway
Global Female 8 Alcohol (liters per capita), Education (years per capita), Mean BMI, Alcohol binge drinker proportion, age- 
standardised, Log- transformed SEV scalar: F Body Aspn, Sociodemographic Index, Healthcare access and quality 
index, Lag distributed income per capita (I$)
Pulmonary aspiration 
and foreign body in 
airway
Data rich Female 6 Alcohol (liters per capita), Lag distributed income per capita (I$), Mean BMI, Log- transformed SEV scalar: F Body 
Aspn, Sociodemographic Index, Healthcare Access and Quality Index
Foreign body in other 
body part
Global/Data rich Male 10 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 m 
(proportion), Log- transformed SEV scalar: Oth F Body, Sociodemographic Index, Healthcare Access and Quality 
Index, Lag distributed income per capita (I$)
Foreign body in other 
body part
Global/Data rich Female 10 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 m 
(proportion), Log- transformed SEV scalar: Oth F Body, Sociodemographic Index, Healthcare Access and Quality 
Index, Lag distributed income per capita (I$)
Environmental heat 
and cold exposure
Global/Data rich Male 11 Education (years per capita), Lag distributed income per capita (I$), Population- weighted mean temperature, 
Elevation Over 1500 m (proportion), Elevation 500 to 1500 m (proportion), Population Density (150–300 
ppl/sqkm, proportion), Rainfall (Quintiles 4–5), Sanitation (proportion with access), 90th percentile climatic 
temperature in the given country- year, Sociodemographic Index, Healthcare Access and Quality Index
Environmental heat 
and cold exposure
Global/Data rich Female 11 Education (years per capita), Lag distributed income per capita (I$), Population- weighted mean temperature, 
Elevation Over 1500 m (proportion), Elevation 500 to 1500 m (proportion), Population Density (150–300 
ppl/sqkm, proportion), Rainfall (Quintiles 4–5), Sanitation (proportion with access), 90th percentile climatic 
temperature in the given country- year, Sociodemographic Index, Healthcare Access and Quality Index
Other unintentional 
injuries
Global/Data rich Male 12 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 m 
(proportion), Vehicles–two wheels (per capita), Vehicles–four wheels (per capita), Log- transformed SEV scalar: 
Oth Unint, Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Other unintentional 
injuries
Global/Data rich Female 12 Alcohol (liters per capita), Education (years per capita), Elevation Over 1500 m (proportion), Population Density 
(over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), Elevation Under 100 m 
(proportion), Vehicles–two wheels (per capita), Vehicles–four wheels (per capita), Log- transformed SEV scalar: 
Oth Unint, Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Self- harm Global Male 11 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Sociodemographic Index, Healthcare Access and Quality Index, Muslim Religion (proportion of population), Lag 
distributed income per capita (I$)
Self- harm Global Female 15 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Log- transformed SEV scalar: Self Harm, Sociodemographic Index, Major 
depressive disorder, Risk of selfharm due to major depressive disorder, Healthcare Access and Quality Index, Non- 
partner lifetime prevalence of sexual violence (female- only), Lag distributed income per capita (I$)
Self- harm Data rich Male 11 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Sociodemographic Index, Healthcare Access and Quality Index, Lag distributed 
income per capita (I$)
Self- harm Data rich Female 13 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Log- transformed SEV scalar: Self Harm, Sociodemographic Index, Major 
depressive disorder, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Self- harm by firearm Global/Data rich Male 13 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Log- transformed SEV scalar: Self Harm, Sociodemographic Index, Major 
depressive disorder, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Self- harm by firearm Global/Data rich Female 13 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Log- transformed SEV scalar: Self Harm, Sociodemographic Index, Major 
depressive disorder, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Self- harm by other 
specified means
Global/Data rich Male 13 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Log- transformed SEV scalar: Self Harm, Sociodemographic Index, Major 
depressive disorder, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Self- harm by other 
specified means
Global/Data rich Female 13 Alcohol (liters per capita), Education (years per capita), Population Density (150–300 ppl/sqkm, proportion), 
Population Density (300–500 ppl/sqkm, proportion), Population Density (500–1000 ppl/sqkm, proportion), 
Population Density (over 1000 ppl/sqkm, proportion), Population Density (under 150 ppl/sqkm, proportion), 
Religion (binary,>50% Muslim), Log- transformed SEV scalar: Self Harm, Sociodemographic Index, Major 
depressive disorder, Healthcare Access and Quality Index, Lag distributed income per capita (I$)
Interpersonal violence Global/Data rich Male 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Violence, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
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Interpersonal violence Global/Data rich Female 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Violence, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Physical violence by 
firearm
Global/Data rich Male 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Viol Gun, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Physical violence by 
firearm
Global/Data rich Female 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Viol Gun, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Physical violence by 
sharp object
Global/Data rich Male 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Viol Knife, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Physical violence by 
sharp object
Global/Data rich Female 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Viol Knife, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Physical violence by 
other means
Global/Data rich Male 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Oth Viol, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Physical violence by 
other means
Global/Data rich Female 8 Alcohol (liters per capita), Education (years per capita), Opium Cultivation (binary), Population Density (over 
1000 ppl/sqkm, proportion), Log- transformed SEV scalar: Oth Viol, Sociodemographic Index, Healthcare Access 
and Quality Index, Lag distributed income per capita (I$)
Executions and police 
conflict
Global/Data rich Male 6 Alcohol (liters per capita), Education (years per capita), Lag distributed income per capita (I$), Population Density 
(over 1000 ppl/sqkm, proportion), Sociodemographic Index, Healthcare Access and Quality Index
Executions and police 
conflict
Global/Data rich Female 6 Alcohol (liters per capita), Education (years per capita), Lag distributed income per capita (I$), Population Density 
(over 1000 ppl/sqkm, proportion), Sociodemographic Index, Healthcare Access and Quality Index
BMI, body mass index.
Table 4 Continued
Figure 1 Cause of Death Ensemble model with data points for road injuries in Colombia for females.
Similar to the principles described in CODEm, DisMod uses 
all available data, ranging from incidence data to cause- specific 
mortality rates from the corrected CODEm results, to produce 
estimates for every age, sex, year and location. For the purposes 
of injuries, we established our case definition for non- fatal inju-
ries as injuries that require medical care. This is a necessary case 
definition as we do not want to consider minor stumbles and 
falls, for example, that led to no actual bodily harm as injuries for 
GBD, since they would not have any associated disability. These 
models are conducted only for injury causes as opposed to the 
nature of injuries references above. Each data input is designated 
based on type of data—specifically, inpatient data, outpatient 
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Figure 2 Cause of Death Ensemble model with data points for road injuries in Honduras for females
Figure 3 Injuries non- fatal estimation flow chart.
data, surveillance data, survey data and literature studies that are 
population- representative. We model incidence rates for hospital 
admissions for injuries, so the non- inpatient data sources get 
adjusted according to their classification so that the model inputs 
are consistent as injuries that warranted or received inpatient 
medical care. The coefficients measured by DisMod that were 
used for adjustment are provided in table 5. Input data for injury 
cause incidence models included sources identified as part of 
systematic reviews conducted in past GBD cycles, new sources 
identified by the GBD collaborator network and new sources of 
clinical data and other injuries data obtained by the core injuries 
burden estimation team at the Institute for Health Metrics and 
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Table 5 Covariates and coefficients used in Global Burden of Disease incidence cause models
Cause Outpatient coefficient Injury receiving formal care, inpatient 
and outpatient coefficient
Injury warranting medical care 
coefficient
Animal contact 7.04 (7.03–7.04) 7.56 (6.91–8.31)
Non- venomous animal contact 2.91 (2.91–2.92) 11.21 (10.1–12.38)
Venomous animal contact 3.14 (3.01–3.34) 4.09 (3.69–4.5)
Drowning 0.88 (0.87–0.89) 1.01 (1.0–1.05) 30.42 (15.33–51.11)
Falls 6.91 (6.89–6.94) 5.94 (5.5–6.46) 9.73 (9.28–10.22)
Fire, heat and hot substances 3.53 (3.53–3.56) 7.82 (7.24–8.51)
Pulmonary aspiration and foreign body in airway 3.37 (3.35–3.43) 15.36 (13.93–16.86)
Foreign body in eyes 931.4 (923.34–934.49) 302.06 (251.14–365.04)
Foreign body in other body part 1.97 (1.95–2.01) 20.97 (15.55–26.26)
Interpersonal violence 6.57 (6.56–6.61) 21.43 (13.6–32.79) 46.97 (39.57–53.62)
Assault by firearm 1.36 (1.29–1.44) 1.27 (1.05–1.6) 53.58 (50.65–54.54)
Assault by sharp object 3.18 (2.92–3.5) 2.38 (1.86–3.22) 37.91 (28.3–50.05)
Assault by other means 5.65 (5.44–5.89) 2.44 (2.02–3.2)
Exposure to mechanical forces 12.4 (12.0–12.82) 33.3 (30.51–36.23)
Unintentional firearm injuries 2.71 (2.53–2.9) 4.6 (3.49–6.36)
Other exposure to mechanical forces 12.62 (12.55–12.85) 30.77 (25.74–36.09)
Adverse effects of medical treatment 1.06 (1.06–1.06) 19.81 (17.29–26.1)
Environmental heat and cold exposure 3.91 (3.9–3.94) 17.54 (3.91–49.6)
Other unintentional injuries 13.53 (13.46–13.78) 14.95 (9.62–24.12)
Poisonings 3.96 (3.73–4.19) 3.78 (3.4–4.21) 8.47 (4.41–16.64)
Poisoning by carbon monoxide 5.86 (5.68–5.92)
Poisoning by other means 4.18 (3.9–4.5)
Self- harm 2.75 (2.75–2.78) 2.5 (2.2–2.83)
Self- harm by firearm 2.77 (2.42–3.07) 16.94 (2.81–51.06)
Self- harm by other specified means 1.5 (1.47–1.51) 6.73 (2.78–19.14)
Other transport injuries 1.65 (1.6–1.77) 1.01 (1.0–1.03)
Road injuries 3.77 (3.75–3.78) 6.16 (5.65–6.68) 15.44 (13.25–18.1)
Motorcyclist road injuries 1.94 (1.92–1.99)
Motor vehicle road injuries 4.48 (4.46–4.48)
Other road injuries 6.9 (6.89–6.96)
Cyclist road injuries 4.54 (4.33–4.89)
Pedestrian road injuries 1.94 (1.94–1.96) 15.78 (7.63–36.6)
Evaluation at the University of Washington. In addition, CSMRs 
from the corrected CODEm models described above are used 
in this stage of DisMod modelling. The list of non- fatal injury 
sources used in GBD 2017 is provided in online supplementary 
appendix table 2. The completed DisMod models for inpatient 
incidence for each cause of injury are publicly available at https:// 
vizhub. healthdata. org/ epi/.
Once an incidence cause model is constructed for each cause of 
injury, an extensive analytical ‘pipeline’ follows which converts 
injury cause incidence into years lived with disability. First, 
inpatient incidence is split into inpatient and outpatient inci-
dence using coefficients empirically measured by DisMod. The 
outpatient coefficients for each injury cause are also included 
in table 5. Separate pipelines are then conducted for inpatient 
and outpatient injury incidence—each step below can be consid-
ered to have been run for both streams of data, for each cause 
of injury. After the coefficient is applied, incidence is adjusted 
by the excess mortality rate measured by DisMod to essentially 
remove injury cases that died after the injury occurred. Once 
these deaths are removed from the incidence pool, the resulting 
steps are applied to these surviving cases of injury. First, each 
new case of injury is considered to have 47 possible ‘natures’ 
of injury that can result. These are the types of bodily injury 
that are considered to be possible outcomes from a given injury 
cause. The proportion of new cases of injury that would have 
some nature of injury as the most disabling outcome is deter-
mined based on dual- coded clinical data sources where both 
the cause and nature of injury were included as ICD codes.10 
Of note, one limitation of this process is that due to computa-
tional demands, it is currently only possible to apportion the 
most disabling nature of injury for each new case of injury. 
As such, the probability that each nature of injury is the most 
disabling nature of injury for some cause of injury is modelled 
in a Dirichlet regression such that the probabilities sum to 1. In 
other words, each nature of injury has some probability of being 
the most disabling injury suffered by the victim of some cause of 
injury, but if multiple natures of injury occurred, then the less 
disabling injuries are not captured as part of that injury cause’s 
disability. This limitation has been recognised as a limitation of 
GBD injury burden estimation in various peer- reviewed articles 
and will likely be addressed in future GBD updates as computa-
tional efficiency improves.3 10
The probability distributions of each cause- nature are 
computed separately for each age, sex, year and location. At this 
point, the analytical stage has the age- specific, sex- specific, year- 
specific, location- specific incidence of a cause- nature combina-
tion, for example, the incidence of road injuries that led to a 
cervical- level spinal cord injury in males aged 20–24 years in 
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Table 6 Short- term disability weights for each nature of injury
Nature of injury
Short- term disability 
weight
Spinal cord lesion at neck level 0.7319
Spinal cord lesion below neck level 0.6235
Foreign body in respiratory system 0.4079
Lower airway burns 0.3764
Severe chest Injury 0.3685
Internal haemorrhage in abdomen and pelvis 0.3242
Burns, ≥20% total burned surface area or ≥10% burned 
surface area if head/neck or hands/wrist involved without 
lower airway burns
0.3145
Fracture of pelvis 0.2788
Fracture of hip 0.2575
Multiple fractures, dislocations, crashes, wounds, sprains 
and strains
0.2575
Drowning and non- fatal submersion 0.2471
Asphyxiation 0.2471
Moderate TBI 0.2137
Poisoning requiring urgent care 0.1628
Burns, <20% total burned surface area without lower 
airway burns
0.1408
Effect of different environmental factors 0.1334
Complications following therapeutic procedures 0.1334
Crush injury 0.1325
Foreign body in GI and urogenital system 0.1143
Dislocation of knee 0.1134
Fracture of femur, other than femoral neck 0.1114
Fracture of vertebral column 0.1106
Minor TBI 0.11
Fracture of sternum and/or fracture of one or more ribs 0.1027
Nerve injury 0.0997
Fracture of skull 0.0714
Fracture of face bones 0.0669
Dislocation of shoulder 0.062
Injury to eyes 0.0543
Fracture of patella, tibia or fibula or ankle 0.0501
Fracture of clavicle, scapula or humerus 0.0349
Fracture of radius and/or ulna 0.0281
Fracture of foot bones except ankle 0.026
Dislocation of hip 0.0159
Foreign body in ear 0.0133
Fracture of hand (wrist and other distal part of hand) 0.0099
Muscle and tendon injuries, including sprains and strains 
lesser dislocations
0.0075
Contusion in any part of the body 0.0075
Superficial injury of any part of the body 0.0075
Open wound(s) 0.0058
GI, gastrointestinal; TBI, traumatic brain injury.
2017 in Stockholm, Sweden. The next step converts these inci-
dence estimates into short- term and long- term injury incidence 
estimates, where long- term disability is defined as having a lower 
functional status 1 year postinjury than at the time of injury. 
These probabilities were measured using long- term follow- up 
studies.14–20 For some natures of injury, such as lower extremity 
amputation, the probability of being a long- term injury is 1. 
The probabilities of short- term versus long- term injury for 
each cause- nature combination are used to split the incidence 
values into short- term and long- term pipelines. The long- term 
incidence is then converted to prevalence using the ordinary 
differential equation solver used in DisMod, which also uses as 
an input excess mortality estimated for certain natures of injury 
such as traumatic brain injury and spinal cord injury conducted 
in a previous systematic review and meta- analysis. The short- 
term incidence is converted to prevalence by multiplying inci-
dence and duration of injury, where duration of injury was either 
computed directly from follow- up studies or, in the case of 
unavailable data, estimated by an expert clinical panel involved 
in previous iterations of the GBD study. Since access to medical 
treatment is assumed to affect duration of injury and disability, 
the GBD Healthcare Access and Quality Index is used to estimate 
the proportion with and without access to medical treatment on 
a location- specific basis.21 The average duration for short- term 
injury is therefore calculated as the percentage treated multiplied 
by treated duration added to the percentage untreated multiplied 
by the untreated duration. The output from this step is the short- 
term prevalence of each cause- nature combination. Short- term 
prevalence is subtracted from long- term prevalence at this stage 
to avoid double counting the same case of injury. Once short- 
term and long- term prevalence estimates for each cause- nature 
are computed, then disability weights as derived by the Salomon 
et al process are assigned to each injury nature.22 Short- term 
disability weights by injury nature are shown in table 6, which 
does not include amputations since we assume they cause only 
long- term disability. The full list of long- term disability weights 
by injury nature, location and year are provided in online 
supplementary appendix table 3, which does not include foreign 
body in respiratory system, foreign body in gastrointestinal and 
urogenital system, foreign body in ear and superficial injury of 
any part of body, since we assume these natures of injury do not 
cause long- term disability. After disability weights are assigned 
to each injury case, years lived with disability for each cause of 
injury are calculated as the prevalence of each health state multi-
plied by the corresponding disability weight and then summed 
across natures of injury for each cause to compute years lived 
with disability (YLDs) for each age, sex, year and location for 
that injury cause. YLDs then undergo comorbidity adjustment 
used across the GBD study whereby comorbid cases of disease 
and injury in the population are simulated and adjusted disability 
weights are computed. These processes are described in more 
detail in GBD literature.3 GBD 2017 provided an important 
methodological update whereby nature of injury results, regard-
less of cause of injury, could be reviewed in the results from this 
process; this has enabled more advanced GBD research such as 
measuring the burden of traumatic brain injury and spinal cord 
injury, measuring the burden of facial fractures and measuring 
the burden of hand and finger fractures.10
Sexual violence
Sexual violence follows a different analytical pathway than the 
other causes of injury. This process is shown in figure 4. We used 
the same study framework as was developed for other injury 
rates in the GBD 2017 study to estimate the yearly propor-
tion of the population that experienced at least one episode 
of sexual violence in the past year, using a case definition of 
any sexual assault including penetrative sexual violence (rape) 
and non- penetrative sexual violence (other forms of unwanted 
sexual touching). To inform the sexual violence estimates, we 
identified data in 93 countries that met the case definition 
above. This resulted in 263 site- years of data, which mainly 
were derived from surveys such as Demographic and Health 
Surveys and Reproductive Health Surveys. Similar to our other 
injury models, we used DisMod 2.1 to model prevalence. The 
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Figure 4 Sexual violence estimation flow chart. HAQI, Healthcare Access and Quality Index.
sexual violence prevalence model used study- level covariates 
for each type of survey question, for example, we used a study- 
level covariate to identify surveys that identify penetrative 
sexual violence only to account for how the overall incidence of 
sexual violence is greater than this value. This model also used a 
covariate on alcohol use in litres per capita for each location to 
help fit the model in data- sparse locations. Once yearly preva-
lence was measured, sexual violence cases undergo a process by 
which short- term disability from the physical and psychological 
harm of sexual violence cases is assigned to each prevalent case; 
however, long- term sequelae of sexual violence are currently not 
captured in this process, which has been a known limitation of 
sexual violence estimation in the GBD framework.
Disability-adjusted life-years
After estimation of cause- specific mortality and YLLs as well as 
non- fatal health outcomes estimation including YLDs, DALYs are 
calculated as the sum of YLLs and YLDs for each cause of injury. 
YLDs are also calculated for each nature of injury category.
GATHER statement
GBD 2017 adheres to the Guidelines for Accurate and Trans-
parent Health Estimates Reporting (GATHER). GATHER is 
described in more detail in online supplementary appendix 2.
RESULTS
Results for all GBD 2017 injury estimates are available in associ-
ated publications as well as online. Specifically, results by age, sex, 
year, subnational location and nature of injury can be viewed and 
downloaded online via the GBD Results Tool (http:// ghdx. health-
data. org/ gbd- results- tool) and GBD Compare (https:// vizhub. 
healthdata. org/ gbd- compare/). These results are available in terms 
of incidence, prevalence, YLDs, cause- specific mortality, YLLs and 
DALYs, expressed in counts, rates, and percentages. Analytical 
code and input datasets are available at http:// ghdx. healthdata. org.
CODEm models
Model performance metrics for each injury cause model in GBD 
2017 are provided in table 7. Model performance metrics for 
CODEm models include root mean square error (RMSE) for 
in- sample tests and out- of- sample tests, percentage of data points 
that correctly predict the trend in- sample and out- of- sample 
and percentage of data points that are present within the 95% 
uncertainty intervals (UIs) of the model fit. RMSE in- sample is 
generally better than RMSE out- of- sample, which is an expected 
result that also demonstrates the importance of performing 
out- of- sample predictive validity tests. While the correct trend 
is predicted in approximately one in five models, this may also 
be related to more dynamic temporal trends in injury mortality 
patterns over time. In general, most data points exist within 
the 95% UI of the model fit (mean: 98.5% in-sample, 98.0% 
out- of- sample).
Incidence models
Model performance metrics for each injury cause model in GBD 
2017 are provided in table 8. These model performance metrics 
include in- sample coverage and RMSE of estimated results for 
cause- specific mortality, excess mortality and incidence. There 
are no performance metrics for CSMR or excess mortality for 
foreign body in eyes since we do not estimate mortality from this 
cause of injury. For incidence, the in- sample coverage average 
was 55.3% across cause- of- injury models and ranged from a 
low of 26% in falls to a high of 88% in poisoning by carbon 
monoxide. Incidence RMSE ranged from a low of 1.04 in pedes-
trian road injuries to a high of 4.86 in foreign body in eye.
DISCUSSION
Many considerable advancements have been made in the 
measurement of global injury burden since early versions of the 
GBD Study. Novel datasets, sophisticated statistical modelling 
and global collaboration have all facilitated the advancement of 
injury burden measurement science. Many more advancements 
in future updates should be possible as larger datasets become 
available and as computational power allows for more detailed 
measurement processes. Continued global collaboration will be 
an integral component. Suggested priority items for the advance-
ment of injury burden estimation are as follows:
First, while much of the global injury burden occurs in low- 
income and middle- income countries, these countries are 
frequently the most data- sparse. GBD has rigorously attempted 
to collect all available data, including police records and verbal 
autopsy studies and inpatient and outpatient records; however, 
it is likely that additional data sources in data- sparse countries 
exist. Parties who are aware of additional data sources that 
could be used in the GBD estimation framework should consider 
joining the GBD collaborator network to contribute new sources 
of data to be used in future estimation updates.
Second, computational and data limitations make it difficult 
to account for the full disability that might be experienced in the 
setting of multiple injuries. For example, if an individual sustains a 
below- neck spinal injury and an upper extremity amputation, the 
amputation is not directly accounted for in the prevalence or YLD 
estimate of the injury cause to which this disability is attributed. 
This problem quickly grows in complexity, as one can imagine an 
event like a road injury leading to multiple contusions and abrasions, 
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Table 7 Performance metrics for each cause- of- injury CODEm model
Cause Type Sex RMSE in- sample RMSE out- of- sample
Per cent coverage 
in- sample
Per cent coverage 
out- of- sample
Transport injuries Data rich Female 0.153062 0.211028 0.999851 0.999395
Transport injuries Data rich Male 0.144423 0.202366 0.99978 0.998995
Transport injuries Global Female 0.216405 0.338398 0.99951 0.992996
Transport injuries Global Male 0.209561 0.327954 0.999347 0.99108
Road injuries Data rich Female 0.154916 0.22011 0.999945 0.999642
Road injuries Data rich Male 0.147432 0.208989 0.99987 0.999452
Road injuries Global Female 0.198002 0.338885 0.999736 0.993674
Road injuries Global Male 0.193896 0.321219 0.999332 0.990834
Pedestrian road injuries Data rich Female 0.183693 0.327964 0.999776 0.998965
Pedestrian road injuries Data rich Male 0.177994 0.323544 0.999688 0.998913
Pedestrian road injuries Global Female 0.240151 0.430127 0.999174 0.992328
Pedestrian road injuries Global Male 0.247329 0.409191 0.998229 0.990017
Cyclist road injuries Data rich Female 0.219965 0.435983 0.999892 0.999106
Cyclist road injuries Data rich Male 0.206919 0.500591 0.999876 0.999158
Cyclist road injuries Global Female 0.296895 0.528063 0.998384 0.990875
Cyclist road injuries Global Male 0.294776 0.527441 0.998702 0.988234
Motorcyclist road 
injuries
Data rich Female 0.268406 0.653692 0.999776 0.998805
Motorcyclist road 
injuries
Data rich Male 0.195368 0.444714 0.999793 0.998395
Motorcyclist road 
injuries
Global Female 0.362655 0.692762 0.998726 0.99082
Motorcyclist road 
injuries
Global Male 0.283024 0.502588 0.998804 0.987794
Motor vehicle road 
injuries
Data rich Female 0.167766 0.33083 0.99993 0.999335
Motor vehicle road 
injuries
Data rich Male 0.160584 0.309726 0.999919 0.999377
Motor vehicle road 
injuries
Global Female 0.230946 0.38664 0.99957 0.995355
Motor vehicle road 
injuries
Global Male 0.232898 0.378096 0.999353 0.992869
Other road injuries Data rich Female 0.408852 1.04171 0.997205 0.970506
Other road injuries Data rich Male 0.467256 1.21047 0.994429 0.9463
Other road injuries Global Female 0.558784 0.899497 0.994899 0.96375
Other road injuries Global Male 0.654189 1.0708 0.984753 0.931697
Other transport injuries Data rich Female 0.255843 0.406371 0.999581 0.998655
Other transport injuries Data rich Male 0.195575 0.404214 0.999666 0.99863
Other transport injuries Global Female 0.31846 0.546918 0.998599 0.991384
Other transport injuries Global Male 0.267514 0.49731 0.998444 0.989304
Falls Data rich Female 0.162773 0.237492 0.999873 0.999522
Falls Data rich Male 0.157114 0.220452 0.999847 0.999492
Falls Global Female 0.246877 0.428822 0.99923 0.988577
Falls Global Male 0.246101 0.369118 0.999571 0.989585
Drowning Data rich Female 0.177905 0.258172 0.999932 0.999782
Drowning Data rich Male 0.164617 0.226899 0.999868 0.999373
Drowning Global Female 0.238598 0.428467 0.999657 0.992777
Drowning Global Male 0.224438 0.361879 0.99961 0.989534
Fire, heat and hot 
substances
Data rich Female 0.175426 0.245 0.999962 0.999793
Fire, heat and hot 
substances
Data rich Male 0.17054 0.227618 0.999944 0.999737
Fire, heat and hot 
substances
Global Female 0.281428 0.401798 0.999483 0.994548
Fire, heat and hot 
substances
Global Male 0.289708 0.40982 0.999518 0.99422
Poisonings Data rich Female 0.190498 0.283924 0.999901 0.999732
Poisonings Data rich Male 0.189747 0.283639 0.999888 0.999668
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Cause Type Sex RMSE in- sample RMSE out- of- sample
Per cent coverage 
in- sample
Per cent coverage 
out- of- sample
Poisonings Global Female 0.311328 0.515718 0.99918 0.993385
Poisonings Global Male 0.323815 0.529806 0.999166 0.992089
Poisoning by carbon 
monoxide
Data rich Female 0.255034 0.352342 0.999119 0.998139
Poisoning by carbon 
monoxide
Data rich Male 0.234913 0.328692 0.999486 0.998765
Poisoning by carbon 
monoxide
Global Female 0.353393 0.688269 0.998372 0.982832
Poisoning by carbon 
monoxide
Global Male 0.305615 0.621778 0.999006 0.983458
Poisoning by other 
means
Data rich Female 0.208468 0.470199 0.999861 0.998144
Poisoning by other 
means
Data rich Male 0.231395 0.543185 0.999871 0.998948
Poisoning by other 
means
Global Female 0.284383 0.555132 0.999746 0.989287
Poisoning by other 
means
Global Male 0.288098 0.590913 0.999759 0.990146
Exposure to mechanical 
forces
Data rich Female 0.171902 0.29354 0.999636 0.99932
Exposure to mechanical 
forces
Data rich Male 0.162641 0.259268 0.999605 0.998955
Exposure to mechanical 
forces
Global Female 0.398855 0.54379 0.995672 0.987855
Exposure to mechanical 
forces
Global Male 0.325975 0.454021 0.995758 0.985214
Unintentional firearm 
injuries
Data rich Female 0.207177 0.502831 0.999619 0.999488
Unintentional firearm 
injuries
Data rich Male 0.221533 0.49235 0.999306 0.998449
Unintentional firearm 
injuries
Global Female 0.354152 0.591674 0.998979 0.991558
Unintentional firearm 
injuries
Global Male 0.355798 0.64953 0.996524 0.980841
Other exposure to 
mechanical forces
Data rich Female 0.20287 0.436518 0.999912 0.999795
Other exposure to 
mechanical forces
Data rich Male 0.170292 0.318704 0.999896 0.999761
Other exposure to 
mechanical forces
Global Female 0.406425 0.538089 0.995379 0.98994
Other exposure to 
mechanical forces
Global Male 0.361646 0.472713 0.995528 0.988955
Adverse effects of 
medical treatment
Data rich Female 0.186809 0.305147 0.999832 0.999511
Adverse effects of 
medical treatment
Data rich Male 0.217278 0.342415 0.999833 0.999577
Adverse effects of 
medical treatment
Global Female 0.280204 0.430453 0.999698 0.993818
Adverse effects of 
medical treatment
Global Male 0.277028 0.431272 0.999573 0.992957
Animal contact Data rich Female 0.277226 0.439671 0.999355 0.998642
Animal contact Data rich Male 0.231627 0.414921 0.999863 0.999528
Animal contact Global Female 0.401714 0.691306 0.998669 0.987713
Animal contact Global Male 0.316647 0.623446 0.9991 0.99176
Venomous animal 
contact
Data rich Female 0.417726 0.745234 0.960501 0.956152
Venomous animal 
contact
Data rich Male 0.401006 0.761481 0.977149 0.97478
Venomous animal 
contact
Global Female 0.634642 0.915323 0.965066 0.949503
Table 7 Continued
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Cause Type Sex RMSE in- sample RMSE out- of- sample
Per cent coverage 
in- sample
Per cent coverage 
out- of- sample
Venomous animal 
contact
Global Male 0.449848 0.839185 0.97819 0.96024
Non- venomous animal 
contact
Data rich Female 0.304776 0.593881 0.994547 0.991865
Non- venomous animal 
contact
Data rich Male 0.304223 0.529077 0.998929 0.998113
Non- venomous animal 
contact
Global Female 0.421204 0.680417 0.995082 0.9848
Non- venomous animal 
contact
Global Male 0.471148 0.740524 0.998707 0.990622
Foreign body Data rich Female 0.170699 0.275966 0.999937 0.999705
Foreign body Data rich Male 0.166161 0.263143 0.999798 0.999305
Foreign body Global Female 0.216832 0.401408 0.999535 0.992467
Foreign body Global Male 0.227414 0.381598 0.999262 0.989838
Pulmonary aspiration 
and foreign body in 
airway
Data rich Female 0.174424 0.374749 0.999979 0.999572
Pulmonary aspiration 
and foreign body in 
airway
Data rich Male 0.178947 0.34741 0.999928 0.999294
Pulmonary aspiration 
and foreign body in 
airway
Global Female 0.267697 0.416038 0.999413 0.993624
Pulmonary aspiration 
and foreign body in 
airway
Global Male 0.286472 0.422915 0.998089 0.990215
Foreign body in other 
body part
Data rich Female 0.31229 0.664465 0.99005 0.987846
Foreign body in other 
body part
Data rich Male 0.291172 0.629172 0.993547 0.991666
Foreign body in other 
body part
Global Female 0.462299 0.749894 0.98392 0.971743
Foreign body in other 
body part
Global Male 0.478614 0.759133 0.984301 0.971436
Other unintentional 
injuries
Data rich Female 0.266367 0.450437 0.999612 0.999067
Other unintentional 
injuries
Data rich Male 0.228051 0.387409 0.999597 0.998959
Other unintentional 
injuries
Global Female 0.354782 0.671813 0.997343 0.984969
Other unintentional 
injuries
Global Male 0.301256 0.54085 0.997963 0.985982
Self- harm Data rich Female 0.157456 0.236415 0.999699 0.999206
Self- harm Data rich Male 0.150967 0.223371 0.999688 0.999011
Self- harm Global Female 0.219988 0.370761 0.998551 0.986222
Self- harm Global Male 0.203341 0.347213 0.999389 0.979274
Self- harm by firearm Data rich Female 0.215778 0.439608 0.992476 0.992525
Self- harm by firearm Data rich Male 0.19323 0.402898 0.998082 0.997457
Self- harm by firearm Global Female 0.311061 0.642889 0.987894 0.971118
Self- harm by firearm Global Male 0.316945 0.590367 0.992646 0.977377
Self- harm by other 
specified means
Data rich Female 0.162023 0.345661 0.999855 0.998854
Self- harm by other 
specified means
Data rich Male 0.235129 0.322581 0.999898 0.999453
Self- harm by other 
specified means
Global Female 0.191636 0.38357 0.999636 0.98601
Self- harm by other 
specified means
Global Male 0.192311 0.348953 0.999813 0.986603
Interpersonal violence Data rich Female 0.224081 0.294307 0.99863 0.996721
Interpersonal violence Data rich Male 0.220852 0.298197 0.998132 0.995665
Table 7 Continued
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Cause Type Sex RMSE in- sample RMSE out- of- sample
Per cent coverage 
in- sample
Per cent coverage 
out- of- sample
Interpersonal violence Global Female 0.306086 0.450697 0.998456 0.989396
Interpersonal violence Global Male 0.307439 0.479452 0.997588 0.981596
Physical violence by 
firearm
Data rich Female 0.253283 0.414003 0.998598 0.997318
Physical violence by 
firearm
Data rich Male 0.277353 0.501753 0.997843 0.996142
Physical violence by 
firearm
Global Female 0.44617 0.621002 0.993619 0.98712
Physical violence by 
firearm
Global Male 0.41286 0.679294 0.995867 0.981991
Physical violence by 
sharp object
Data rich Female 0.222036 0.393235 0.999815 0.999003
Physical violence by 
sharp object
Data rich Male 0.235542 0.463121 0.999796 0.998721
Physical violence by 
sharp object
Global Female 0.276474 0.499795 0.999526 0.993622
Physical violence by 
sharp object
Global Male 0.332336 0.595217 0.999354 0.990212
Physical violence by 
other means
Data rich Female 0.204351 0.336239 0.999954 0.999532
Physical violence by 
other means
Data rich Male 0.202192 0.394188 0.999868 0.999051
Physical violence by 
other means
Global Female 0.270287 0.410186 0.999719 0.995718
Physical violence by 
other means
Global Male 0.285589 0.45387 0.999612 0.992595
Environmental heat and 
cold exposure
Data rich Female 0.234754 0.399463 0.999403 0.999073
Environmental heat and 
cold exposure
Data rich Male 0.201821 0.309939 0.999658 0.999207
Environmental heat and 
cold exposure
Global Female 0.3511 0.639869 0.998595 0.989061
Environmental heat and 
cold exposure
Global Male 0.33441 0.528137 0.999336 0.993068
Executions and police 
conflict
Data rich Female 0.852242 1.4431 0.49803 0.533053
Executions and police 
conflict
Data rich Male 0.970597 1.55607 0.629313 0.628953
Executions and police 
conflict
Global Female 1.2422 1.86518 0.541687 0.549016
Executions and police 
conflict
Global Male 1.04755 1.95756 0.671496 0.659889
CODEm, Cause of Death Ensemble model.
Table 7 Continued
several fractures in different anatomical sites, a mild traumatic brain 
injury and a spinal cord injury. There are over 3.6 million permu-
tations of injury if one considers only 10 possible natures of injury, 
making it difficult to quantitatively measure these relationships by 
cause of injury and by age, sex, year and location. Future research to 
address this limitation may focus on simulation studies that model 
the probability of different comorbid injury combinations to better 
inform disability weight applications.
Third, more data could be used for nature of injury measure-
ment. Traumatic brain injury and spinal cord injury registries, for 
example, are not currently directly compatible with the GBD injury 
estimation framework yet provide rich epidemiological informa-
tion. Future updates to GBD should focus more attention on incor-
porating data that measure burden of nature of injury in terms of 
incidence, prevalence or excess mortality. Incorporating these types 
of data would require a method to be developed such that estimates 
were internally consistent across cause- nature distributions. While 
the methods and data required for this update would be complex, 
they would represent a large increase in the available data that could 
be used for GBD injuries estimation.
Fourth, measuring the total burden of sexual violence has proven 
to be a challenging area of estimation in the GBD framework. As 
noted in the ‘Methods’ section of this paper, one known limitation 
is how long- term sequelae and conditions may not be adequately 
accounted for in sexual violence burden estimation. In order to 
attribute burden from major depressive disorder, anxiety disorders, 
self- harm and substance use disorders, measuring the relative risk 
of developing these conditions for victims of sexual violence would 
allow for population attributable fractions to be calculated and 
DALYs from these conditions to be attributed to sexual violence. 
While the premise of this methodological update is relatively simple, 
currently there are relatively few studies to inform these relative 
risks, and conducting and adding such studies in the future would 
be recognised as a major achievement in GBD research as it would 
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Table 8 Performance metrics for each cause- of- injury DisMod model
Cause
Cause- specific mortality 
rate:
in- sample coverage
Cause- specific mortality 
rate: in- sample RMSE
Excess mortality rate:
in- sample coverage
Excess mortality rate:
in- sample RMSE
Incidence hazard: in- 
sample coverage
Incidence hazard:
in- sample RMSE
Animal contact 0.95 0.96 0.69 1.14 0.40 1.64
Non- venomous animal contact 0.97 0.98 0.74 1.20 0.53 1.40
Venomous animal contact 0.97 1.13 0.74 1.17 0.48 1.31
Drowning 0.91 0.82 0.84 1.40 0.73 1.61
Falls 0.93 0.66 0.71 1.13 0.26 1.77
Fire, heat and hot substances 0.95 0.59 0.67 0.97 0.50 1.16
Pulmonary aspiration and foreign 
body in airway
0.92 0.93 0.78 1.29 0.65 1.56
Foreign body in eyes 0.83 4.86
Foreign body in other body part 0.96 1.40 0.74 1.31 0.57 1.39
Interpersonal violence 0.89 0.81 0.64 1.11 0.31 1.77
Assault by firearm 0.93 1.96 0.74 1.07 0.69 1.25
Assault by sharp object 0.92 1.50 0.78 1.05 0.57 1.17
Assault by other means 0.90 0.91 0.75 1.10 0.48 1.33
Exposure to mechanical forces 0.92 0.81 0.61 1.23 0.38 2.01
Unintentional firearm injuries 0.95 1.51 0.75 1.13 0.70 1.17
Other exposure to mechanical 
forces
0.93 0.84 0.66 1.22 0.41 1.94
Adverse effects of medical 
treatment
0.92 0.71 0.71 1.48 0.37 1.41
Environmental heat and cold 
exposure
0.94 1.21 0.73 1.54 0.56 1.52
Other unintentional injuries 0.89 1.31 0.51 1.35 0.50 1.67
Poisonings 0.95 0.90 0.76 1.75 0.58 1.90
Poisoning by carbon monoxide 0.95 0.94 0.81 1.11 0.88 1.17
Poisoning by other means 0.95 0.92 0.79 1.89 0.67 2.04
Self- harm 0.98 0.27 0.76 1.02 0.47 1.32
Self- harm by firearm 1.00 1.28 0.89 1.31 0.86 1.35
Self- harm by other specified 
means
0.98 0.26 0.83 0.96 0.60 1.06
Other transport injuries 0.96 0.99 0.73 1.43 0.63 1.32
Road injuries 0.91 0.47 0.63 1.10 0.27 1.43
Motorcyclist road injuries 0.96 1.07 0.70 1.13 0.54 1.18
Motor vehicle road injuries 0.94 0.55 0.59 1.12 0.48 1.21
Other road injuries 0.99 1.45 0.78 1.16 0.74 1.19
Cyclist road injuries 0.99 1.13 0.73 1.10 0.59 1.09
Pedestrian road injuries 0.92 0.72 0.62 1.02 0.48 1.04
RMSE, root mean square error .
allow for more accurate estimation of lifetime disability caused by 
sexual violence. This effort would moreover represent an important 
contribution to research surrounding the Sustainable Development 
Goals related to sexual violence and women’s rights. 23 24
Fifth, non- fatal injuries from conflict and natural disaster 
are challenging to estimate because of data sparsity in areas 
that are afflicted by these events. Fatalities are estimated after 
such events, but there is still considerable injury burden among 
the population that survives. Since data collection systems and 
hospitals may also be destroyed in these events, it becomes 
difficult to collect adequate non- fatal injury data. Global 
collaboration should also focus on identifying sources of data 
on non- fatal and fatal injury cases in conflict and natural 
disaster events.
It will be important to monitor the effects of implementing 
these priorities as injury measurement science continues to 
evolve. Global collaborations including the GBD enterprise 
should monitor performance statistics and utilisation of results 
by research groups and ministries to track how improvements 
to injury measurement progress over time. Scientific dialogue 
and collaboration must be a major focus, and the GBD enter-
prise is a good forum to support this kind of data sharing. 
For example, a collaborative effort between researchers in 
Vietnam and the Institute for Health Metrics on Evaluation on 
developing a study on Vietnam injury burden following GBD 
2017 led to identifying the use of the Vietnam National Injury 
Survey, which was then added for estimation in GBD 2019. 
Increasing data collection standardisation efforts should be 
emphasised as a priority in all countries, particularly countries 
where data coverage on injuries is sparse. Ongoing dialogue 
via scientific publications and international conferences 
should also continue to serve as a forum to discuss data and 
methodological updates that can continue to refine the science 
of injuries estimation in GBD.
CONCLUSION
Measuring injuries burden in GBD is a complex scientific 
endeavour that leverages large amounts of data, a complex 
analytical framework and a global research network. GBD 2017 
included more comprehensive detail of injury burden than any 
other known efforts to date. GBD 2019 and future updates will 
continue to add detail and refine methods in the interest of 
providing injury burden estimates that are robust, accurate and 
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timely. Expanded injury data collection efforts will be a critical 
component of future injury burden estimation.
What is already known on the subject
 ► Global Burden of Disease (GBD) 2017 provided an extensive 
peer- reviewed assessment of death and disability.
 ► GBD 2017 methods have been reviewed and updated 
iteratively as new methods and data become available.
 ► Measuring injury burden in GBD 2017 is complex due to 
differences in measuring cause of injury versus nature of 
injury and the temporal difference between them.
What this study adds
 ► This capstone study details key estimation methods that are 
used for measuring the global burden of injuries as described 
in related publications in this journal.
 ► More detailed methods descriptions and model performance 
metrics from GBD 2017 are provided in this study than in 
related studies.
 ► This study also includes suggested future directions for 
improving injury burden research.
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Paulo, Brazil
205Internal Medicine Department, University of São Paulo, Sao Paulo, Brazil
206Department of Dermatology, Boston University, Boston, MA, USA
207Institute of Public Health, United Arab Emirates University, Al Ain, United Arab 
Emirates
208Instituto de Patologia Tropical e Saúde Pública, Federal University of Goias, 
Goiânia, Brazil
209Department of Epidemiology and Biostatistics, Zhengzhou University, Zhengzhou, 
China
210Non- Communicable Diseases (NCD), World Health Organization (WHO), New 
Delhi, India
211Department of Public Health, Erasmus University Medical Center, Rotterdam, 
Netherlands
212Global and Community Mental Health Research Group, University of Macau, 
Macao, China
213Department of Family and Community Medicine, Arabian Gulf University, 
Manama, Bahrain
214School of Health and Environmental Studies, Hamdan Bin Mohammed Smart 
University, Dubai, United Arab Emirates
215Biomedical Research Networking Center for Mental Health Network (CiberSAM), 
Madrid, Spain
216Research and Development Unit, San Juan de Dios Sanitary Park, Sant Boi de 
Llobregat, Spain
217Department of Microbiology, Maragheh University of Medical Sciences, Maragheh, 
Iran
218Department of Microbiology, Tehran University of Medical Sciences, Tehran, Iran
219Centre for International Health and Section for Ethics and Health Economics, 
University of Bergen, Bergen, Norway
220Gastrointestinal and Liver Disease Research Center, Guilan University of Medical 
Sciences, Rasht, Iran
221Guilan University of Medical Sciences, Rasht, Iran
222School of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran
223Independent Consultant, Tabriz, Iran
224Department of Public Health, Mizan- Tepi University, Tepi, Ethiopia
225Unit of Epidemiology and Social Medicine, University Hospital Antwerp, Wilrijk, 
Belgium
226Department of Clinical Sciences, Karolinska University Hospital, Stockholm, 
Sweden
227Medical Biology Research Center, Kermanshah University of Medical Sciences, 
Kermanshah, Iran
228Research Coordination, AC Environments Foundation, Cuernavaca, Mexico
229CISS, National Institute of Public Health, Cuernavaca. Mexico
230Department of Urban Planning and Design, University of Hong Kong, Hong Kong, 
China
231Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi 
Minh City, Vietnam
232Department of Pediatrics, Dell Medical School, University of Texas Austin, Austin, 
TX, USA
233Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
234Department of Pharmacology and Therapeutics, Dhaka Medical College, Dhaka, 
Bangladesh
235Department of Pharmacology, Bangladesh Industrial Gases Limited, Tangail, 
Bangladesh
236Department of Computer Engineering, Islamic Azad University, Tehran, Iran
237Computer Science Department, University of Human Development, Sulaymaniyah, 
Iraq
238Department of Legal Medicine and Bioethics, Carol Davila University of Medicine 
and Pharmacy, Bucharest, Romania
239Clinical Legal Medicine Department, National Institute of Legal Medicine Mina 
Minovici, Bucharest, Romania
240Department of Epidemiology and Health Statistics, Central South University, 
Changsha, China
241Department of Health Promotion and Education, University of Ibadan, Ibadan, 
Nigeria
242Department of Community Medicine, University of Ibadan, Ibadan, Nigeria
243Department of Family Medicine, Bangalore Baptist Hospital, Bangalore, India
244Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical 
Sciences, Tehran, Iran
245School of Psychology and Public Health, La Trobe University, Bundoora, 
Melbourne, Victoria, Australia
246Institute for Physical Activity and Nutrition, Deakin University, Burwood, Victoria, 
Australia
247Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
248School of Public Health and Community Medicine, University of New South Wales, 
Sydney, New South Wales, Australia
249Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
250Department for Health Care and Public Health, Sechenov First Moscow State 
Medical University, Moscow, Russia
251Social Development & Health Promotion Research Center, Kermanshah University 
of Medical Sciences, Kermanshah, Iran
252Department of Surgery, Virginia Commonwealth University, Richmond, VA, USA
253Institute of Medicine, University of Colombo, Colombo, Sri Lanka
254Faculty of Graduate Studies, University of Colombo, Colombo, Sri Lanka
255Department of Community Medicine, Banaras Hindu University, Varanasi, India
256Health Promotion and Education, University of Ibadan, Ibadan, Nigeria
257Department of Ophthalmology, Heidelberg University, Mannheim, Germany
258Beijing Ophthalmology & Visual Science Key Laboratory, Beijing Tongren Hospital, 
Beijing, China
259Auckland University of Technology, Auckland, New Zealand
260Community Medicine Department, Manipal Academy of Higher Education, 
Mangalore, India
261Department of Family Medicine and Public Health, University of Opole, Opole, 
Poland
262School of Health Sciences, Savitribai Phule Pune University, Pune, India
263Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
264Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, 
Tehran, Iran
265Department of Medical Informatics, Tabriz University of Medical Sciences, Tabriz, 
Iran
266Social Determinants of Health Research Center, Research Institute for Prevention 
of Non- Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, 
Iran
267Health Services Management Department, Qazvin University of Medical Sciences, 
Qazvin, Iran
268School of Public Health, Department of Health informatics and Health Innovation, 
A.C.S. Medical College and Hospital, Mekelle, Ethiopia
269Department of Forensic Medicine and Toxicology, All India Institute of Medical 
Sciences, Jodhpur, India
270Department of Epidemiology, Hamadan University of Medical Sciences, Hamadan, 
Iran
271Hematology- Oncology and Stem Cell Transplantation Research Center, Tehran 
University of Medical Sciences, Tehran, Iran
272Pars Advanced and Minimally Invasive Medical Manners Research Center, Iran 
University of Medical Sciences, Tehran, Iran
273Department of Applied Physics, The John Paul II Catholic University of Lublin, 
Lublin Voivodeship, Poland
274Department of Biology and Chemistry, Drohobych Ivan Franko State Pedagogical 
University, Drohobych, Ukraine
275International Research Center of Excellence, Institute of Human Virology Nigeria, 
Abuja, Nigeria
276Julius Centre for Health Sciences and Primary Care, Utrecht University, Utrecht, 
Netherlands
277Open, Distance and eLearning Campus, University of Nairobi, Nairobi, Kenya
278Department of Dermatology, Wolaita Sodo University, Wolaita Sodo, Ethiopia
279Department of Public Health, Jordan University of Science and Technology, Irbid, 
Jordan
280Social Determinants of Health Research Center, Ahvaz Jundishapur University of 
Medical Sciences, Ahvaz, Iran
281School of Food and Agricultural Sciences, University of Management and 
Technology, Lahore, Pakistan
282Department of Global Health, University of Washington, Seattle, WA, USA
283Department of Physiology, Baku State University, Baku, Azerbaijan
284Epidemiology, Faculty of Public Health and Tropical Medicine, Jazan University, 
Jazan, Saudi Arabia
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285Epidemiology and Biostatistics Department, Health Services Academy, Islamabad, 
Pakistan
286Department of Population Studies, International Institute for Population Sciences, 
Mumbai, India
287Department of Health Research, Indian Council of Medical Research, New Delhi, 
India
288Centre for Ethics, Jawahar Lal Nehru University, New Delhi, India
289Department of Psychiatry, Kermanshah University of Medical Sciences, 
Kermanshah, Iran
290Nuffield Department of Surgical Sciences, Oxford University Global Surgery Group, 
University of Oxford, Oxford, UK
291Research and Data Solutions, Synotech Consultant, Nairobi, Kenya
292Department of Preventive Medicine, Korea University, Seoul, South Korea
293School of Medicine, Xiamen University Malaysia, Sepang, Malaysia
294Department of Health Sciences, Northeastern University, Boston, MA, USA
295Department of Nursing and Health Promotion, Oslo Metropolitan University, Oslo, 
Norway
296School of Health Sciences, Kristiania University College, Oslo, Norway
297Neurophysiology Research Center, Hamadan University of Medical Sciences, 
Hamadan, Iran
298Brain Engineering Research Center, Institute for Research in Fundamental 
Sciences, Tehran, Iran
299Public Health Dentistry Department, Krishna Institute of Medical Sciences Deemed 
to be University, Karad, India
300Environmental Health Engineering, Arak University of Medical Sciences, Arak, Iran
301CIBERSAM, San Juan de Dios Sanitary Park, Sant Boi de Llobregat, Spain
302Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
303Department of Zoology, University of Oxford, Oxford, UK
304Harvard Medical School, Harvard University, Boston, MA, USA
305Department of Anthropology, Panjab University, Chandigarh, India
306Department of Demography, University of Montreal, Montreal, Quebec, Canada
307Department of Social and Preventive Medicine, University of Montreal, Montreal, 
Quebec, Canada
308Department of Public Health, Yuksek Ihtisas University, Ankara, Turkey
309Department of Public Health, Hacettepe University, Ankara, Turkey
310Department of Family and Community Health, University of Health and Allied 
Sciences, Ho, Ghana
311Department of Psychology and Health Promotion, University of KwaZulu- Natal, 
Durban, South Africa
312Community Medicine Department, Kasturba Medical College, Manipal Academy of 
Higher Education, Mangalore, India
313Department of Psychiatry, University of Nairobi, Nairobi, Kenya
314Division of Psychology and Language Sciences, University College London, 
London, UK
315Department of Medicine Brigham and Women’s Hospital, Harvard University, 
Boston, MA, USA
316Orthopaedics Department, Base Hospital Lucknow Cantt, Lucknow, India
317Mechanical and Industrial Engineering, Indian Institute of Technology, Roorkee, 
India
318Department of Community and Family Medicine, University of Baghdad, Baghdad, 
Iraq
319HelpMeSee, New York, NY, USA
320International Relations, Mexican Institute of Ophthalmology, Queretaro, Mexico
321Department of Otorhinolaryngology (ENT), Father Muller Medical College, 
Mangalore, India
322Department of Public Health, Maragheh University of Medical Sciences, Maragheh, 
Iran
323Institute of Clinical Physiology, National Research Council, Pisa, Italy
324Clinical Medicine and Community Health, University of Milan, Milano, Italy
325College of Optometry, Nova Southeastern University, Fort Lauderdale, FL, USA
326School of Pharmacy, Monash University, Bandar Sunway, Malaysia
327School of Pharmacy, Taylor’s University Lakeside Campus, Subang Jaya, Malaysia
328Department of Systems, Populations and Leadership, University of Michigan, Ann 
Arbor, MI, USA
329Department of Health Metrics Sciences, School of Medicine, University of 
Washington, Seattle, WA, USA
330Department of Medicine, University of São Paulo, Sao Paulo, Brazil
331Health Data Research UK, Swansea University, Swansea, UK
332Center for Integration of Data and Health Knowledge, FIOCRUZ: Cidacs Center for 
Integration of Data and Health Knowledge, Salvador, Brazil
333Faculty of Epidemiology and Population Health, London School of Hygiene & 
Tropical Medicine, England
334Pathology Department, College of Medicine, Imam Abdulrahman Bin Faisal 
University, Dammam, Saudi Arabia
335Ophthalmology Department, Aswan Faculty of Medicine, Aswan, Egypt
336Institute of Medicine, Tribhuvan University, Kathmandu, Nepal
337Department of Public Health, Trnava University, Trnava, Slovakia
338Department of Primary Care and Public Health, Imperial College London, London, 
UK
339Health Education and Research Department, SDM College of Medical Sciences & 
Hospital, Dharwad, India
340Health University, Rajiv Gandhi University of Health Sciences, Bangalore, India
341Department of Maternal and Child Nursing and Public Health, Federal University 
of Minas Gerais, Belo Horizonte, Brazil
342Ophthalmology Department, Iran University of Medical Sciences, Tehran, Iran
343Ophthalmology Department, University of Manitoba, Winnipeg, Manitoba, Canada
344Department of Surgery, University of Virginia, Charlottesville, VA, USA
345Surgery Department, Emergency University Hospital Bucharest, Bucharest, 
Romania
346Psychiatry Department, National Institute of Mental Health and Neurosciences, 
Bengaluru, India
347Department of Epidemiology and Biostatistics, Tehran University of Medical 
Sciences, Tehran, Iran
348Institute for Social Science Research, The University of Queensland, Brisbane, 
Queensland, Australia
349Department of Health Sciences, University of York, York, UK
350Department of Midwifery- Reproductive Health, Hamadan University of Medical 
Sciences, Hamadan, Iran
351Research Department, The George Institute for Global Health, New Delhi, India
352School of Medicine, University of New South Wales, Sydney, New South Wales, 
Australia
353Neurology Department, Janakpuri Super Specialty Hospital Society, New Delhi, 
India
354Department of Neurology, Govind Ballabh Institute of Medical Education and 
Research, New Delhi, India
355Division of Epidemiology and Prevention, Institute of Human Virology, University 
of Maryland, Baltimore, MD, USA
356Peru Country Office, United Nations Population Fund (UNFPA), Lima, Peru
357Forensic Medicine Division, Imam Abdulrahman Bin Faisal University, Dammam, 
Saudi Arabia
358Department of Epidemiology and Biostatistics, Haramaya University, Harar, 
Ethiopia
359Breast Surgery Unit, Helsinki University Hospital, Helsinki, Finland
360University of Helsinki, Helsinki, Finland
361Neurocenter, Helsinki University Hospital, Helsinki, Finland
362School of Health Sciences, University of Melbourne, Parkville, Victoria, Australia
363Statistics Department, Debre Markos University, Debre Markos, Ethiopia
364Clinical Microbiology and Parasitology Unit, Zora Profozic Polyclinic, Zagreb, 
Croatia
365University Centre Varazdin, University North, Varazdin, Croatia
366Center for Innovation in Medical Education, Pomeranian Medical University, 
Szczecin, Poland
367Pomeranian Medical University, Szczecin, Poland
368Department of Propedeutics of Internal Diseases & Arterial Hypertension, 
Pomeranian Medical University, Szczecin, Poland
369Pacific Institute for Research & Evaluation, Calverton, MD, USA
370Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for 
Medical Sciences and Technology, Trivandrum, India
371Global Institute of Public Health (GIPH), Ananthapuri Hospitals and Research 
Centre, Trivandrum, India
372Department of Statistics and Econometrics, Bucharest University of Economic 
Studies, Bucharest, Romania
373President’s Office, National Institute of Statistics, Bucharest, Romania
374Faculty of Internal Medicine, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
375Department of Atherosclerosis and Coronary Heart Disease, National Center of 
Cardiology and Internal Disease, Bishkek, Kyrgyzstan
376Heidelberg Institute of Global Health (HIGH), Faculty of Medicine and University 
Hospital, Heidelberg University, Heidelberg, Germany
377Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, 
Frankfurt, Germany
378Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
379Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, 
Iran
380Health Equity Research Center, Tehran University of Medical Sciences, Tehran, Iran
381Internal Medicine Department, King Saud University, Riyadh, Saudi Arabia
382Department of Information Technology, University of Human Development, 
Sulaymaniyah, Iraq
383Department of Epidemiology and Biostatistics, Shahrekord University of Medical 
SciencesShahrekord, Iran
384Department of Nursing, Shahroud University of Medical Sciences, Shahroud, Iran
385Health Systems and Policy Research Unit, Ahmadu Bello University, Zaria, Nigeria
386Department of Public Health, Samara University, Samara, Ethiopia
387Iran National Institute of Health Research, Tehran University of Medical Sciences, 
Tehran, Iran
 on N
ovem
ber 2, 2020 by guest. P
rotected by copyright.
http://injuryprevention.bm
j.com
/
Inj P
rev: first published as 10.1136/injuryprev-2019-043531 on 24 A
ugust 2020. D
ow
nloaded from
 
James SL, et al. Inj Prev 2020;26:i125–i153. doi:10.1136/injuryprev-2019-043531i150
Original research
388Pediatric Neurorehabilitation Research Center, University of Social Welfare and 
Rehabilitation Sciences, Tehran, Iran
389Faculty of Life Sciences and Medicine, King’s College London, London, UK
390Clinical Epidemiology and Public Health Research Unit, Burlo Garofolo Institute for 
Maternal and Child Health, Trieste, Italy
391Department of Public Health Medicine, University of KwaZulu- Natal, Durban, 
South Africa
392Research Center for Environmental Determinants of Health, Kermanshah 
University of Medical Sciences, Kermanshah, Iran
393Kermanshah University of Medical Sciences, Kermanshah, Iran
394Social Determinants of Health Research Center, Kurdistan University of Medical 
Sciences, Sanandaj, Iran
395Department of Epidemiology and Biostatistics, Kurdistan University of Medical 
Sciences, Sanandaj, Iran
396Preventive Medicine and Public Health Research Center, Iran University of Medical 
Sciences, Tehran, Iran
397International Laboratory for Air Quality and Health, Queensland University of 
Technology, Brisbane, Queensland, Australia
398Gorgas Memorial Institute for Health Studies, Panama City, Panama
399Department of Psychiatry, Badhir Dar University, Ethiopia
400Department of Epidemiology and Biostatistics, University of Gondar, Gondar, 
Ethiopia
401School of Medical Sciences, Science University of Malaysia, Kubang Kerian, 
Malaysia
402Department of Pediatric Medicine, Nishtar Medical University, Multan, Pakistan
403Department of Pediatrics & Pediatric Pulmonology, Institute of Mother & Child 
Care, Multan, Pakistan
404Clinical Research Development Center, Kermanshah University of Medical 
Sciences, Kermanshah, Iran
405Research and Analytics, Initiative for Financing Health and Human Development, 
Chennai, India
406Research and Analytics, Bioinsilico Technologies, Chennai, India
407Department of Epidemiology, University of Alabama at Birmingham, Birmingham, 
AL, USA
408Laboratory of Public Health Indicators Analysis and Health Digitalization, Moscow 
Institute of Physics and Technology, Dolgoprudny, Russia
409Experimental Surgery and Oncology Laboratory, Kursk State Medical University of 
the Ministry of Health of the Russian Federation, Kursk, Russia
410Department of Epidemiology & Biostatistics, Kermanshah University of Medical 
Sciences, Kermanshah, Iran
411Suraj Eye Institute, Nagpur, India
412Hospital of the Federal University of Minas Gerais, Federal University of Minas 
Gerais, Belo Horizonte, Brazil
413Mental Health Research Center, IUMS, Tehran, Iran
414Preventive Medicine and Public Health Research Center, IUMS, Tehran, Iran
415Department of Forensic Medicine and Toxicology, Manipal Academy of Higher 
Education, Manipal, India
416Department of Pediatrics, Arak University of Medical Sciences, Arak, Iran
417Iranian Ministry of Health and Medical Education, Tehran, Iran
418Cochrane South Africa, South African Medical Research Council, Cape Town, South 
Africa
419Department of General Surgery, Carol Davila University of Medicine and 
Pharmacy, Bucharest, Romania
420Department of General Surgery, Emergency Hospital of Bucharest, Bucharest, 
Romania
421Department of Biological Sciences, University of Embu, Embu, Kenya
422Institute for Global Health Innovations, Duy Tan University, Hanoi, Vietnam
423Project of ADB, National Institute of Nutrition, Hanoi, Vietnam
424Industrial Management Department, Hanoi University of Science and Technology, 
Hanoi, Vietnam
425Department of Pharmacology, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran
426Heidelberg University Hospital, Heidelberg, Germany
427Public Health Department, Universitas Negeri Semarang, Kota Semarang, 
Indonesia
428Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei City, 
Taiwan
429School of Public Health and Family Medicine, University of Cape Town, Cape Town, 
South Africa
430Centre of Cardiovascular Research and Education in Therapeutics, Monash 
University, Melbourne, Victoria, Australia
431Independent Consultant, Accra, Ghana
432UCIBIO, University of Porto, Porto, Portugal
433Reproductive Health Sciences, Department Obstetrics and Gynecology, University 
of Ibadan, Ibadan, Nigeria
434Department of Preventive Medicine, Kyung Hee University, Dongdaemun- gu, 
South Korea
435Department of Psychiatry and Behavioural Neurosciences, McMaster University, 
Hamilton, Ontario, Canada
436Department of Psychiatry, University of Lagos, Lagos, Nigeria
437Department of Pathology and Molecular Medicine, McMaster University, Hamilton, 
Ontario, Canada
438Diplomacy and Public Relations Department, University of Human Development, 
Sulaimaniyah, Iraq
439Department of Pharmacology and Therapeutics, University of Nigeria Nsukka, 
Enugu, Nigeria
440Applied Research Division, Public Health Agency of Canada, Ottawa, Ontario, 
Canada
441School of Psychology, University of Ottawa, Ottawa, Ontario, Canada
442Department of Global Health Nursing, St. Luke’s International University, Chuo- ku, 
Japan
443Academic Department, Unium Ltd, Moscow, Russia
444Department of Project Management, National Research University Higher School 
of Economics, Moscow, Russia
445Department of Respiratory Medicine, Jagadguru Sri Shivarathreeswara Academy of 
Health Education and Research, Mysore, India
446Department of Forensic Medicine, Manipal Academy of Higher Education, Manipal, 
India
447Department of Medicine, Ottawa Hospital Research Institute, Ottawa Hospital, 
Ottawa, Ontario, Canada
448Parasitology and Mycology Department, Shiraz University of Medical Sciences, 
Shiraz, Iran
449Augenpraxis Jonas, Heidelberg University, Heidelberg, Germany
450Department of Medical Humanities and Social Medicine, Kosin University, Busan, 
South Korea
451Research and Evaluation Department, Population Council, New Delhi, India
452Indian Institute of Health Management Research University, Jaipur, India
453Department of Pediatircs, RD Gardi Medical College, Ujjain, India
454Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
455Regional Medical Research Centre, Indian Council of Medical Research, 
Bhubaneswar, India
456Department of Midwifery, Wolaita Sodo University, Wolaita Sodo, Ethiopia
457School of Public Health and Community Medicine, Faculty of Medicine, University 
of New South Wales, Sydney, New South Wales, Australia
458Center for Research and Innovation, Ateneo De Manila University, Pasig City, 
Philippines
459Department of Orthopedics, Yenepoya Medical College, Mangalore, India
460Department of Psychiatry, Department of Epidemiology, Columbia University, New 
York, NY, USA
461Shanghai Mental Health Center, Shanghai Jiao Tong University, Shanghai, China
462Department of Epidemiology and Evidence- Based Medicine, Sechenon University, 
Moscow, Russia
463School of Population and Public Health, University of British Columbia, Vancouver, 
British Columbia, Canada
464Digestive Diseases Research Institute, Tehran University of Medical Sciences, 
Tehran, Iran
465Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical 
Sciences, Lucknow, India
466Health Sciences Department, Muhammadiyah University of Surakarta, Sukoharjo, 
Indonesia
467Department of Chemistry, Sharif University of Technology, Tehran, Iran
468Biomedical Engineering Department, Amirkabir University of Technology, Tehran, 
Iran
469College of Medicine, University of Central Florida, Orlando, FL, USA
470College of Graduate Health Sciences, A.T. Still University, Mesa, AZ, USA
471Department of Epidemiology & Biostatistics, Contech School of Public Health, 
Lahore, Pakistan
472Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
473Department of Immunology, Mazandaran University of Medical Sciences, Sari, Iran
474Molecular and Cell Biology Research Center, Mazandaran University of Medical 
Sciences, Sari, Iran
475Thalassemia and Hemoglobinopathy Research Center, Ahvaz Jundishapur 
University of Medical Sciences, Ahvaz, Iran
476Metabolomics and Genomics Research Center, Tehran University of Medical 
Sciences, Tehran, Iran
477Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
478School of Nursing and Healthcare Professions, Federation University Australia, 
Berwick, Victoria, Australia
479School of Nursing and Midwifery, La Trobe University, Melbourne, Victoria, 
Australia
480Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
481European Office for the Prevention and Control of Noncommunicable Diseases, 
World Health Organization (WHO), Moscow, Russia
482Department of Oral Pathology, Srinivas Institute of Dental Sciences, Mangalore, 
India
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483School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, 
Tehran, Iran
484Academic Public Health Department, Public Health England, London, UK
485School of Health, Medical and Applied Sciences, CQ University, Sydney, New South 
Wales, Australia
486Department of Computer Science, Metropolitan College, Boston University, 
Boston, USA
487Neurology Department, Sree Chitra Tirunal Institute for Medical Sciences and 
Technology, Thiruvananthapuram, India
488Brien Holden Vision Institute, Sydney, New South Wales, Australia
489Organization for the Prevention of Blindness, Paris, France
490EPIUnit - Public Health Institute University Porto (ISPUP), University of Porto, Porto, 
Portugal
491Surgery Department, University of Minnesota, Minneapolis, MN, USA
492Surgery Department, University Teaching Hospital of Kigali, Kigali, Rwanda
493Research Directorate, Nihon Gakko University, Fernando de la Mora, Paraguay
494Research Direction, Universidad Nacional de Caaguazú, Coronel Oviedo, Paraguay
495Department of Clinical Research, Federal University of Uberlândia, Uberlândia, 
Brazil
496Golestan Research Center of Gastroenterology and Hepatology, Golestan 
University of Medical Sciences, Gorgan, Iran
497College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
498Department of Health in Disasters and Emergencies, Shahid Beheshti University of 
Medical Sciences, Tehran, Iran
499Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran
500Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, 
Tehran, Iran
501Nanobiotechnology Center, Soran University, Soran, Iraq
502Public Health and Community Medicine Department, Cairo University, Giza, Egypt
503Urology Department, Cairo University, Giza, Egypt
504Health and Disability Intelligence Group, Ministry of Health, Wellington, New 
Zealand
505Department of Entomology, Ain Shams University, Cairo, Egypt
506Department of Surgery, Marshall University, Huntington, WV, USA
507Department of Nutrition and Preventive Medicine, Case Western Reserve 
University, Cleveland, OH, USA
508Rheumatology Department, University Hospitals Bristol NHS Foundation Trust, 
Bristol, UK
509Institute of Bone and Joint Research, University of Sydney, Syndey, New South 
Wales, Australia
510Institute of Social Medicine, University of Belgrade, Belgrade, Serbia
511Centre- School of Public Health and Health Management, University of Belgrade, 
Belgrade, Serbia
512Health Economics, Bangladesh Institute of Development Studies (BIDS), Dhaka, 
Bangladesh
513Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
514Surgery Department, Hamad Medical Corporation, Doha, Qatar
515Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, UK
516Department of Public Health Sciences, University of North Carolina at Charlotte, 
Charlotte, NC, USA
517Education Development Center, Faculty Member of Education Development 
Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
518Department of Psychology, University of Alabama at Birmingham, Birmingham, 
AL, USA
519Department of Psychiatry, Stellenbosch University, Cape Town, South Africa
520Emergency Department, Manian Medical Centre, Erode, India
521Microbiology Service, National Institutes of Health, Bethesda, MD, USA
522Center for Biomedical Information Technology, Shenzhen Institutes of Advanced 
Technology, Chinese Academy of Sciences, Shenzhen, China
523Department of Health Promotion and Education, Alborz University of Medical 
Sciences, Karaj, Iran
524Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
525Independent Consultant, Karachi, Pakistan
526School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
527Centre for Medical Informatics, University of Edinburgh, Edinburgh, UK
528Division of General Internal Medicine, Harvard University, Boston, MA, USA
529National Institute of Infectious Diseases, Tokyo, Japan
530College of Medicine, Yonsei University, Seodaemun- gu, South Korea
531Division of Cardiology, Emory University, Atlanta, GA, USA
532Finnish Institute of Occupational Health, Helsinki, Finland
533Department of Health Education & Promotion, Kermanshah University of Medical 
Sciences, Kermanshah, Iran
534School of Health, University of Technology Sydney, Sydney, New South Wales, 
Australia
535Department of Psychology, Reykjavik University, Reykjavik, Iceland
536Department of Health and Behavior Studies, Columbia University, New York, NY, 
USA
537Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 
USA
538Medicine Service, US Department of Veterans Affairs (VA), Birmingham, AL, USA
539Department of Forensic Medicine, Kathmandu University, Dhulikhel, Nepal
540Department of Epidemiology, School of Preventive Oncology, Patna, India
541Department of Epidemiology, Healis Sekhsaria Institute for Public Health, Mumbai, 
India
542Medical Surgical Nursing Department, Urmia University of Medical Science, Urmia, 
Iran
543Emergency Nursing Department, Semnan University of Medical Sciences, Semnan, 
Iran
544Hospital Universitario de la Princesa, Autonomous University of Madrid, Madrid, 
Spain
545Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), 
Madrid, Spain
546Department of Public Health, Arba Minch University, Arba Minch, Ethiopia
547Hull York Medical School, University of Hull, Hull City, UK
548Usher Institute of Population Health Sciences and Informatics, University of 
Edinburgh, Edinburgh, UK
549Department of Psychology, Deakin University, Melbourne, Victoria, Australia
550Department of Community Medicine, Ahmadu Bello University, Zaria, Nigeria
551Department of Criminology, Law and Society, University of California Irvine, Irvine, 
CA, USA
552Department of Medicine, University of Valencia, Valencia, Spain
553Carlos III Health Institute, Biomedical Research Networking Center for Mental 
Health Network (CiberSAM), Madrid, Spain
554School of Social Work, University of Illinois, Urbana, IL, USA
555Public Health, Arba Minch College of Health Sciences, Arba Minch, Ethiopia
556School of Public Health, University of Adelaide, Adelaide, SA, Australia
557Department of Environmental Health, Wollo University, Dessie, Ethiopia
558Department of Community and Family Medicine, Iran University of Medical 
Sciences, Tehran, Iran
559Department of Pharmacognosy, Mekelle University, Mekelle, Ethiopia
560Institute of Public Health, University of Gondar, Gondar, Ethiopia
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